tag:blogger.com,1999:blog-67049570476461292472024-03-19T04:11:13.225-07:00Divulga Pesquisa - Farmácia UFRGSPesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.comBlogger36125tag:blogger.com,1999:blog-6704957047646129247.post-18213742337367318092013-05-22T07:10:00.001-07:002013-05-22T07:11:11.812-07:0039ª Semana Acadêmica de Estudos Farmacêuticos - SAEF UFRGS<div style="text-align: center;">
<br /></div>
<div style="text-align: justify;">
Está ocorrendo, durante toda essa semana, as atividades da 39ª SAEF. O evento conta com palestras, cursos, workshops, concursos e mesas redondas a respeito de diversos temas de interesse farmacêutico. A participação dos alunos e profissionais farmacêuticos está sendo muito grande e a satisfação de todos pode ser percebida nas atividades e nos corredores da Faculdade de Farmácia da UFRGS.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Aqui, algumas fotos que foram tiradas nos primeiros dias:</div>
<div style="text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-VqVLOR-brBQ/UZzLyk4H2LI/AAAAAAAAASk/XI_k_4dJsYg/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="320" src="http://1.bp.blogspot.com/-VqVLOR-brBQ/UZzLyk4H2LI/AAAAAAAAASk/XI_k_4dJsYg/s320/image.jpg" width="239" /></a></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-b7RDGlXVRps/UZzJ7TUJtOI/AAAAAAAAAPg/Aflugstlzpk/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="236" src="http://1.bp.blogspot.com/-b7RDGlXVRps/UZzJ7TUJtOI/AAAAAAAAAPg/Aflugstlzpk/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://4.bp.blogspot.com/-YA-JzZsrf0I/UZzJ8HwOyVI/AAAAAAAAAPk/AN8MqvOFIZY/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://4.bp.blogspot.com/-YA-JzZsrf0I/UZzJ8HwOyVI/AAAAAAAAAPk/AN8MqvOFIZY/s320/image.jpg" width="320" /></a></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-b0eKDbmZzuU/UZzJ7eOrbpI/AAAAAAAAAPo/fat1CXqKPGY/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://1.bp.blogspot.com/-b0eKDbmZzuU/UZzJ7eOrbpI/AAAAAAAAAPo/fat1CXqKPGY/s320/image.jpg" width="320" /></a></div>
<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://4.bp.blogspot.com/-L3PRZzyzPlI/UZzKE5vmZ3I/AAAAAAAAAQA/Kjkq8Sa9iVY/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://4.bp.blogspot.com/-L3PRZzyzPlI/UZzKE5vmZ3I/AAAAAAAAAQA/Kjkq8Sa9iVY/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-8YLK4SwC-p0/UZzKCM0fypI/AAAAAAAAAP0/eE8pr2b0Z4k/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://1.bp.blogspot.com/-8YLK4SwC-p0/UZzKCM0fypI/AAAAAAAAAP0/eE8pr2b0Z4k/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-51Ad-m8-Qn8/UZzKDQgfQ-I/AAAAAAAAAP8/Gh7wjAmsIxQ/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://1.bp.blogspot.com/-51Ad-m8-Qn8/UZzKDQgfQ-I/AAAAAAAAAP8/Gh7wjAmsIxQ/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-vDXJ6NnBnxM/UZzKhykMF6I/AAAAAAAAAQo/pW93uMH1GVw/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://3.bp.blogspot.com/-vDXJ6NnBnxM/UZzKhykMF6I/AAAAAAAAAQo/pW93uMH1GVw/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-4NxUJJPPJYM/UZzKJSkWNYI/AAAAAAAAAQQ/FEYC7lLNcX4/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://1.bp.blogspot.com/-4NxUJJPPJYM/UZzKJSkWNYI/AAAAAAAAAQQ/FEYC7lLNcX4/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-q9r2rwB1h1Y/UZzKIzR5scI/AAAAAAAAAQM/J7cIg-7VFQc/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://2.bp.blogspot.com/-q9r2rwB1h1Y/UZzKIzR5scI/AAAAAAAAAQM/J7cIg-7VFQc/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-SGdnwDA7DEE/UZzKjOt0UjI/AAAAAAAAAQ0/KvHguncoqjw/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://1.bp.blogspot.com/-SGdnwDA7DEE/UZzKjOt0UjI/AAAAAAAAAQ0/KvHguncoqjw/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-WsZpdpje0zE/UZzKff4Nh0I/AAAAAAAAAQY/3t2STQ7IDko/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://3.bp.blogspot.com/-WsZpdpje0zE/UZzKff4Nh0I/AAAAAAAAAQY/3t2STQ7IDko/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-gr2GSGrfCxs/UZzKh5phLGI/AAAAAAAAAQs/780o1NjxjWk/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://1.bp.blogspot.com/-gr2GSGrfCxs/UZzKh5phLGI/AAAAAAAAAQs/780o1NjxjWk/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-pIwJRQh_yUQ/UZzKkhkCoRI/AAAAAAAAAQ4/1l6WW5BeIys/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://2.bp.blogspot.com/-pIwJRQh_yUQ/UZzKkhkCoRI/AAAAAAAAAQ4/1l6WW5BeIys/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-EOtJSPdOR0I/UZzK2-dcWAI/AAAAAAAAARc/8FSlV4mN6Pk/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://2.bp.blogspot.com/-EOtJSPdOR0I/UZzK2-dcWAI/AAAAAAAAARc/8FSlV4mN6Pk/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-1nK9FolINWw/UZzKv0J4g3I/AAAAAAAAARA/s-ALYedAHWA/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://3.bp.blogspot.com/-1nK9FolINWw/UZzKv0J4g3I/AAAAAAAAARA/s-ALYedAHWA/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-RxiU2d3u1KQ/UZzK4DalUoI/AAAAAAAAARg/23a_Pmldf0A/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://1.bp.blogspot.com/-RxiU2d3u1KQ/UZzK4DalUoI/AAAAAAAAARg/23a_Pmldf0A/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-u2jxjIdcjEE/UZzK3Wt1neI/AAAAAAAAARY/2aqqN9mQScE/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://3.bp.blogspot.com/-u2jxjIdcjEE/UZzK3Wt1neI/AAAAAAAAARY/2aqqN9mQScE/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/--Kfa0q0hrEQ/UZzKybGcO2I/AAAAAAAAARI/J-pmc98YR54/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://2.bp.blogspot.com/--Kfa0q0hrEQ/UZzKybGcO2I/AAAAAAAAARI/J-pmc98YR54/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://4.bp.blogspot.com/-f1Cg-YEdJuo/UZzLG71vJMI/AAAAAAAAARw/6VqSzTXxv9Q/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://4.bp.blogspot.com/-f1Cg-YEdJuo/UZzLG71vJMI/AAAAAAAAARw/6VqSzTXxv9Q/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-okxhK--EbkA/UZzLGT-6okI/AAAAAAAAARs/BfAt1TSHt4Y/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://1.bp.blogspot.com/-okxhK--EbkA/UZzLGT-6okI/AAAAAAAAARs/BfAt1TSHt4Y/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-2wrHnHXn_94/UZzLdJ2u7oI/AAAAAAAAASI/RgDN7zlNxvI/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://2.bp.blogspot.com/-2wrHnHXn_94/UZzLdJ2u7oI/AAAAAAAAASI/RgDN7zlNxvI/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://4.bp.blogspot.com/-_jUqmoOf2Ng/UZzLLjrQJWI/AAAAAAAAASA/idEKUiW_0Do/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://4.bp.blogspot.com/-_jUqmoOf2Ng/UZzLLjrQJWI/AAAAAAAAASA/idEKUiW_0Do/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-vAe3ZGpYejs/UZzLLq91i_I/AAAAAAAAAR8/rqk8V339jes/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://1.bp.blogspot.com/-vAe3ZGpYejs/UZzLLq91i_I/AAAAAAAAAR8/rqk8V339jes/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-Z20w1gGRlhc/UZzLssLDanI/AAAAAAAAASY/63JphetbkxM/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://2.bp.blogspot.com/-Z20w1gGRlhc/UZzLssLDanI/AAAAAAAAASY/63JphetbkxM/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-VKHuKbbRB4I/UZzLsCFNj2I/AAAAAAAAASU/ezlND7KPWm0/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://3.bp.blogspot.com/-VKHuKbbRB4I/UZzLsCFNj2I/AAAAAAAAASU/ezlND7KPWm0/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-bu3EnH9Qs3Q/UZzL1eW3tpI/AAAAAAAAASw/fbW7OvASwS4/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://2.bp.blogspot.com/-bu3EnH9Qs3Q/UZzL1eW3tpI/AAAAAAAAASw/fbW7OvASwS4/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-dt4vJmyCUC4/UZzLz2HO8hI/AAAAAAAAASs/45dadri-SzM/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://2.bp.blogspot.com/-dt4vJmyCUC4/UZzLz2HO8hI/AAAAAAAAASs/45dadri-SzM/s320/image.jpg" width="320" /></a></div>
<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://1.bp.blogspot.com/-jyB4CHyYo0I/UZzMABVjrwI/AAAAAAAAATA/aRq8ELuqEc4/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://1.bp.blogspot.com/-jyB4CHyYo0I/UZzMABVjrwI/AAAAAAAAATA/aRq8ELuqEc4/s320/image.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-tP5IKQ2od-U/UZzL_Z_sNDI/AAAAAAAAAS8/q25tUKJ7BY4/s1600/image.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="239" src="http://3.bp.blogspot.com/-tP5IKQ2od-U/UZzL_Z_sNDI/AAAAAAAAAS8/q25tUKJ7BY4/s320/image.jpg" width="320" /></a></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Para maiores informações do evento, acesse: www.ufrgs.br/saef</div>
Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-4162930260839390282013-04-24T12:53:00.001-07:002013-04-24T12:53:16.235-07:00Globo UniversidadeBoa tarde!<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEho5MtP1VK7roEf4os5etRXIM0d1_hXbMFMSFyJhV8VOniY9O1D3XSh249-oe397KkEAKUL3DDhdwBmimWXu8w8PuMTNrkyl67MeRhNgRWkmTzuriH9hpRWcDwOPWq6cU80Xv5DSKEXD-0/s1600/gu.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEho5MtP1VK7roEf4os5etRXIM0d1_hXbMFMSFyJhV8VOniY9O1D3XSh249-oe397KkEAKUL3DDhdwBmimWXu8w8PuMTNrkyl67MeRhNgRWkmTzuriH9hpRWcDwOPWq6cU80Xv5DSKEXD-0/s1600/gu.jpg" /></a></div>
<br />
A Rede Globo exibiu no último sábado um programa Globo Universidade especial sobre o curso de Farmácia. É uma boa oportunidade de conhecer um pouco mais sobre o curso e a atividade do farmacêutico. Confiram no link abaixo!<br />
<br />
<a href="http://redeglobo.globo.com/globouniversidade/videos/t/edicoes/v/globo-universidade-20042013-farmacos-integra/2524746/" target="_blank">Programa Globo Universidade - Curso de Farmácia</a>Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-88858449466751316212013-04-07T18:30:00.000-07:002013-04-07T18:35:23.343-07:00Impactos da Educação Farmacêutica Continuada - Ms. Márcia dos Angeles<b id="internal-source-marker_0.7956279683858156" style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: black; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;"></b><div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: center; text-indent: 35.45pt;">
<b id="internal-source-marker_0.7956279683858156" style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: black; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;"><span style="background-color: transparent; color: black; font-family: Arial; font-size: 19px; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Impactos da Educação Farmacêutica Continuada <table cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: left; margin-right: 1em; text-align: left;"><tbody>
<tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgE6UKeDR9KNTFItca43R99D99J2zE3oOR-QtlQCt8HCFvfVzMYkUJrFDT7ifj4aa6dBSIHCi-Qwf51WqxbYy32FyXpCISE9CHEAXgajOrhmJTepvISHTsOPlwJai9FVvCBYG6yhmLXWiQ/s1600/705308_3765849718649_1342716170_o.jpg" imageanchor="1" style="clear: left; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><img border="0" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgE6UKeDR9KNTFItca43R99D99J2zE3oOR-QtlQCt8HCFvfVzMYkUJrFDT7ifj4aa6dBSIHCi-Qwf51WqxbYy32FyXpCISE9CHEAXgajOrhmJTepvISHTsOPlwJai9FVvCBYG6yhmLXWiQ/s320/705308_3765849718649_1342716170_o.jpg" width="130" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;"><span style="font-size: xx-small;">Ms. Márcia dos Angeles e Prof. Dr. Mauro de Castro</span></td></tr>
</tbody></table>
</span></b></div>
<b id="internal-source-marker_0.7956279683858156" style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: black; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;">
<div style="text-align: justify;">
<br /></div>
<span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"></span><div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Após a realização do seu mestrado no Programa de Pós Graduação em Ciências Farmacêuticas PPGCF UFRGS, sob a orientação do Prof. Dr. Mauro de Castro, a aluna Márcia dos Angeles Luna Leite está iniciando doutorado na mesma instituição e sob mesma orientação, cujo título provisório é Avaliação de Impactos da Educação Continuada nas Práticas Farmacêuticas na Atenção Primária à Saúde (APS).</span></div>
<div style="text-align: justify;">
<br /></div>
<span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"></span><div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"><span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Como já prevê o título, o trabalho consiste em avaliar os impactos do curso "Farmacêuticos na APS: Construindo uma Relação Integral" dado aos farmacêuticos do Núcleo de Atenção à Saúde da Família - NASF - na sua vida profissional. </span>Márcia pretende identificar as oportunidades e barreiras enfrentadas pelos profissionais para a mudança das práticas nos serviços farmacêuticos e utilizar estas informações para gerar uma nova proposta de capacitação. </span></div>
<div style="text-align: justify;">
<br /></div>
<span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"></span><div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Esse curso foi realizado em 2010 na modalidade à distância em parceria pelo Grupo de Pesquisa e Desenvolvimento em Atenção Farmacêutica - GPDAF -, a Secretaria de Educação à Distância da UFRGS e o Ministério da Saúde. Aconteceram 2 etapas presenciais em três edições de curso que foram em Curitiba - PR, São Luiz - MA, Recife – PE e Porto Alegre - RS. Para saber se houve de fato uma mudança no serviço prestado pelos farmacêuticos, será selecionada uma amostra entre os participantes egressos e eles serão estudados em profundidade. Assim, serão extraídas novas diretrizes para o novo modelo. A pergunta é: repetir ou reformular?</span></div>
<div style="text-align: justify;">
<br /></div>
<span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"></span><div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Para a conclusão do doutorado são necessários 4 anos de trabalho, cursar 36 créditos de aulas, obter proficiência em duas línguas estrangeiras e a defender a tese elaborada para uma banca examinadora.</span></div>
</b><br />Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-73431845329689179082013-03-26T15:41:00.001-07:002013-03-26T15:41:40.818-07:00IC em Histofisiologia Comparada - Otávio Américo Augustin<br />
<div style="text-align: justify;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjt4jVo7sjN2TgJTuPDH3wxg-SEwErT02k2HVKzLAMOJANY00kdcafLfykooJCOXO0BoxOuj0AJLDA8dXmgqBJ6zN6LaL-TtOEEIq4CoXZwILLHo-WmQkxZwkS_GePdLp3d6QKm4k4NOBI/s1600/otavio.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjt4jVo7sjN2TgJTuPDH3wxg-SEwErT02k2HVKzLAMOJANY00kdcafLfykooJCOXO0BoxOuj0AJLDA8dXmgqBJ6zN6LaL-TtOEEIq4CoXZwILLHo-WmQkxZwkS_GePdLp3d6QKm4k4NOBI/s1600/otavio.jpg" /></a><span style="font-family: Arial, Helvetica, sans-serif;"> As atividades dos alunos na iniciação científica são muito diversificadas. Para conhecer melhor a rotina deles, vamos falar do trabalho de alguns deles. Começando a série de matérias, foi entrevistado o aluno Otávio Américo Augustin, bolsista do laboratório de Histofisiologia Comparada, que fica no Instituto de Ciências Básicas da Saúde (ICBS) – UFRGS.</span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"> </span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"> Ele participa de um estudos vinculados ao PPG de Neurociências que investigam os mecanismos de lesão do sistema nervoso em desenvolvimento em ratos Wistar do período pré, peri ou pós-natal, sob a orientação da Prof Dra Simone Marcuzzo. O foco é buscar estratégias neuroprotetoras e terapêuticas que previnam a perda de função e a progressão da patologia observada. Otávio participa de atividades teóricas, como os seminários do laboratório e irá apresentar seu estudo no Salão UFRGS 2013. Já nas atividades práticas, lida no manejo dos animais. Entre as tarefas que executa estão:</span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"> </span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;">- realizar testes comportamentais e motores;</span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"> </span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;">- fazer gavagens (introdução de cânula no esôfago para medicar via oral);</span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"> </span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;">- preparação e análise de lâminas histológicas, preparadas utilizando várias técnicas, como a imunohistoquímica;</span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"> </span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;">- participação dos seminários do laboratório, momento em que são apresentados e discutidos os resultados obtidos nos estudos realizados pelo grupo de pesquisa, bem como são discutidos artigos científicos publicados por outros grupos de pesquisa.</span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"> </span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"> A iniciação científica, como se pode ver, propicia ao aluno o contato com as atividades de pesquisa e expansão dos conhecimentos adquiridos em sala de aula, enriquecendo o currículo e a atividade universitária, além de contribuir para a formação de futuros pesquisadores.</span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"> </span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"> Otávio também é monitor voluntário da disciplina de Histologia, participou da última gestão do Diretório Acadêmico da Faculdade de Farmácia -DAFF UFRGS- e é o atual coordenador da Semana Acadêmica de Estudos Farmacêuticos -SAEF - 2013.</span></div>
Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-56435098542118765342013-03-26T15:10:00.002-07:002013-03-26T15:10:58.744-07:00SEMINÁRIO TEMÁTICO DE INICIAÇÃO CIENTÍFICA: A PESQUISA NA UFRGS<br />
<div style="text-align: justify;">
<span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">Promovido pela Pró-Reitoria de Pesquisa, através da Divisão de Iniciação Científica, o Seminário Temático: “A pesquisa na UFRGS” abordará a pesquisa e a produção de conhecimento na Universidade e que resultados elas têm a oferecer.</span></div>
<div style="text-align: justify;">
<span style="color: #222222; font-family: arial, sans-serif; font-size: 13px;"><br /></span></div>
<span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;"><div style="text-align: justify;">
Palestrante: José Carlos Frantz</div>
</span><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;"><div style="text-align: justify;">
Possui mestrado em Geociências pela Universidade Federal do Rio Grande do Sul (1983) e doutorado em Geologia pela Universidade de Brasília (1997). Realizou programa de Pós-Doutorado em Metalogenia e Modelamento de Depósitos Minerais na University of Western Australia (2001-2002). Trabalhou na Paranapanema (1978-1979), no Departamento Nacional da Produção Mineral (1980-1986), professor da Unisinos (1982-1987) e é professor do Instituto de Geociências da UFRGS desde 1982 atuando no Programa de Pós-graduação em geociências desde 1998. Foi Diretor do Centro de Estudos em Petrologia e Geoquímica (2003-2004) e Diretor do Instituto de Geociências (2005-2012) da UFRGS. Atualmente é Pró-reitor de Pesquisa da UFRGS.</div>
</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">Data: 28 de março (quinta-feira)</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">Para facilitar a participação, esta atividade será realizada em duas edições.</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">Horários e Locais:</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">10h às 11h30min</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">Auditório do Instituto Latino Americano de Estudos Avançados – ILEA</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">Av. Bento Gonçalves, 9500 – Prédio: 43322 | Campus do Vale</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">ou</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">16h às 17h30min</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">Auditório da Faculdade de Ciências Econômicas</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">Av. João Pessoa, 50 | Campus Centro</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">Inscrições:</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">Entrada franca, sem necessidade de inscrição prévia. A presença será registrada no local para posterior emissão de atestado de participação.</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">Mais informações:</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">Pró-Reitoria de Pesquisa | Divisão de Iniciação Científica</span><br style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;" /><span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;">Telefones: 3308 3209, 3308 3766 e 3308 4178</span>Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-28108606430834252352013-03-06T08:58:00.003-08:002013-03-06T08:58:57.422-08:00Iniciação Científica - Juliana Abdalla<div dir="ltr" id="internal-source-marker_0.22202108228216788" style="margin-bottom: 0pt; margin-top: 0pt; text-align: center;">
<span style="font-size: small;"><span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline;">Iniciação Científica - Juliana Abdalla</span></span></div>
<span style="font-size: small;"><span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline;"></span><br /><span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline;"></span></span><div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjMfJpwdoj-5B626b3D1abhlzj1Tj830XSdh75e_dyNU-EmkJ9ln07840aVmpbczFdiO7hfoik6Zgij1PGHBED5rjj-suic85t7oBEhVgO56jifHpCr7fEdlKiPPROOyiJSl9R9rlP2fqY/s1600/juliana.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjMfJpwdoj-5B626b3D1abhlzj1Tj830XSdh75e_dyNU-EmkJ9ln07840aVmpbczFdiO7hfoik6Zgij1PGHBED5rjj-suic85t7oBEhVgO56jifHpCr7fEdlKiPPROOyiJSl9R9rlP2fqY/s1600/juliana.jpg" /></a><span style="font-size: small;"><span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline;">A
aluna Juliana Abdalla atua no Centro Bioanalítico de Medicamentos,
realizando trabalho de farmacocinética, com a orientação da Profª Drª
Teresa Dalla Costa e nos conta um pouco de sua experiência como bolsista
de Iniciação Científica (IC). Juliana já é IC há quase 2 anos, já fez
extensão e está no atual projeto há menos de um mês. Essa é a terceira
vez dela como bolsista e no atual laboratório é onde pretende
permanecer.</span></span></div>
<span style="font-size: small;"><span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline;"></span><br /></span><div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<span style="font-size: small;"><span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline;">Juliana
diz que há diversas oportunidades de bolsa divulgadas pela própria
faculdade. A sua atividade atual envolve o desenvolvimento de métodos
para um projeto de doutorado, que ela está acompanhando desde o início, e
juntamente com a doutoranda faz várias análises e lida com diferentes
equipamentos. A essa última função ela atribui a maior dificuldade da
atividade, pois os equipamentos são complexos, exigem atenção, cuidado e
responsabilidade.</span></span></div>
<span style="font-size: small;"><span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline;"></span><br /></span><div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<span style="font-size: small;"><span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline;">A
integração com o laboratório e o trabalho, ela considera tranqüilo.
Quando os orientadores acompanham a atividade desde o início as coisas
ficam mais fáceis, mas nem todo laboratório tem essa disponibilidade.
Normalmente o aluno precisa de 20 horas semanais para cumprir sua
rotina, mas isso depende do fluxo de trabalho. Já houve situação em sua
trajetória de IC em que precisou realizar experimentos em
finais-de-semana, mas é raro.</span></span></div>
<span style="font-size: small;"><span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline;"></span><br /></span><div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<span style="font-size: small;"><span style="background-color: transparent; color: black; font-family: Arial; font-style: normal; font-variant: normal; font-weight: normal; text-decoration: none; vertical-align: baseline;">Sobre
estar na iniciação, a aluna considera bom porque é uma das atividades
em que mais se aprende sobre o curso e também porque ajuda nas
disciplinas que se está estudando: o conhecimento teórico é colocado em
prática. Ela acredita que, enfim, encontrou o local onde quer trabalhar
até o fim do seu curso, pois gosta bastante do que está fazendo.</span></span></div>
Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-72963524174979990272013-01-22T08:04:00.000-08:002013-01-22T08:04:53.298-08:00Influenza: Ministério da Saúde orienta viajantes<h5 style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; background-color: white; clear: both; color: #4f4d4d; font: bold italic 1em Verdana; letter-spacing: normal; list-style-type: none; margin: 0px; padding-bottom: 5px; padding-top: 20px; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;">
Influenza: Ministério da Saúde orienta viajantes</h5>
<br style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: #4f4d4d; font: 11px Arial, Helvetica, sans-serif; letter-spacing: normal; list-style-type: none; margin: 0px; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;" /><em style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: #4f4d4d; font: 11px Arial, Helvetica, sans-serif; letter-spacing: normal; list-style-type: none; margin: 0px; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; list-style-type: none; margin: 0px;">18 de janeiro de 2013</span></em><span style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: #4f4d4d; display: inline !important; float: none; font: 11px Arial, Helvetica, sans-serif; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;"></span><br />
<div style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: #4f4d4d; font: 12px Arial, Helvetica, sans-serif; letter-spacing: normal; list-style-type: none; margin: 0px; padding-top: 1px; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;">
</div>
<div style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: #4f4d4d; font: 12px Arial, Helvetica, sans-serif; letter-spacing: normal; list-style-type: none; margin: 0px; padding-top: 1px; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;">
<br style="font-family: Arial, Helvetica, sans-serif; list-style-type: none; margin: 0px;" /><span style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;">Os países localizados no Hemisfério Norte encontram-se nesse momento na estação do inverno, quando sempre é mais intensa a circulação do vírus da influenza. As autoridades sanitárias americanas estão alertando que, no atual inverno, a transmissão de influenza teve início mais precocemente e tem sido bastante intensa, situação semelhante à identificada no Canadá, devendo-se observar as medidas de prevenção. Essa variação de intensidade e gravidade dos casos de influenza ocorre normalmente em diferentes anos e está relacionada a fatores climáticos, às características dos sorotipos do vírus de influenza que estão circulando e à maior ou menor proteção fornecida pela vacina utilizada naquele ano. </span></span></div>
<div style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: #4f4d4d; font: 12px Arial, Helvetica, sans-serif; letter-spacing: normal; list-style-type: none; margin: 0px; padding-top: 1px; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;">
<br style="font-family: Arial, Helvetica, sans-serif; list-style-type: none; margin: 0px;" /><span style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;">Os sorotipos do vírus que circulam atualmente nos Estados Unidos e Canadá, de maneira predominante, são o influenza A (H3N2) e o influenza B, que fazem parte da vacina de influenza do Hemisfério Norte que foi utilizada naqueles países desde o final do ano passado e que também integraram a vacina utilizada no Hemisfério Sul, incluindo o Brasil, no primeiro semestre de 2012. Cabe lembrar, entretanto, que a proteção fornecida por essa vacina é parcial e limitada no tempo, exigindo que todas as medidas de prevenção sejam sempre adotadas.</span></span><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;"><br style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;" /></span><span style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;">Não há recomendação de cancelamento de viagens para esses países por parte da Organização Mundial da Saúde (OMS) ou do Ministério da Saúde. Entretanto, é importante que todos aqueles que viajarem para os EUA e Canadá, assim como para qualquer país que agora se encontra na estação do inverno, observem os cuidados de prevenção da influenza. Esses cuidados devem ser observados, particularmente, por aquelas pessoas que apresentam condições que podem favorecer a ocorrência de casos mais graves, como os idosos, as crianças menores de 2 anos, as mulheres grávidas e os portadores de doenças que afetam a imunidade.</span></span><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;"><br style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;" /></span> </div>
<div style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: #4f4d4d; font: 12px Arial, Helvetica, sans-serif; letter-spacing: normal; list-style-type: none; margin: 0px; padding-top: 1px; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;">
<span style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;">As medidas a serem adotadas para a prevenção da influenza são:</span></span><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;"><br style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;" /></span> </div>
<div style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: #4f4d4d; font: 12px Arial, Helvetica, sans-serif; letter-spacing: normal; list-style-type: none; margin: 0px; padding-top: 1px; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;">
<span style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;">1. Procurar evitar contato com pessoas doentes.</span></span></div>
<div style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: #4f4d4d; font: 12px Arial, Helvetica, sans-serif; letter-spacing: normal; list-style-type: none; margin: 0px; padding-top: 1px; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;">
<span style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;">2. Lavar as mãos com água e sabão ou higienizá-las com álcool gel várias vezes ao dia.</span></span></div>
<div style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: #4f4d4d; font: 12px Arial, Helvetica, sans-serif; letter-spacing: normal; list-style-type: none; margin: 0px; padding-top: 1px; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;">
<span style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;">3. Proteger-se da tosse e de espirros com lenços descartáveis.</span></span></div>
<div style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: #4f4d4d; font: 12px Arial, Helvetica, sans-serif; letter-spacing: normal; list-style-type: none; margin: 0px; padding-top: 1px; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;">
<span style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;">4. Não viajar se estiver doente.</span></span><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;"><br style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;" /></span> </div>
<div style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: #4f4d4d; font: 12px Arial, Helvetica, sans-serif; letter-spacing: normal; list-style-type: none; margin: 0px; padding-top: 1px; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;">
<span style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;">A pessoa que estiver viajando e apresentar os sintomas da gripe (febre acompanhada de tosse ou dor na garganta e dor de cabeça) deve procurar imediatamente um médico para que este avalie a necessidade de prescrever antivirais específicos.</span></span><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;"><br style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;" /></span> </div>
<div style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: #4f4d4d; font: 12px Arial, Helvetica, sans-serif; letter-spacing: normal; list-style-type: none; margin: 0px; padding-top: 1px; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;">
<span style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;">Não há obrigatoriedade da vacinação antes de viajar. A vacina contra a gripe é fabricada todos os anos para uso imediato, no período que antecede o inverno. Assim, não há disponibilidade de vacinas contra a gripe no verão. Quem buscar vacinação em clínicas privadas deve observar cuidadosamente o prazo de validade, pois a vacina contra a influenza é preparada apenas para uso durante a estação naquele ano específico.</span></span><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;"><br style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;" /></span> </div>
<div style="-webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; color: #4f4d4d; font: 12px Arial, Helvetica, sans-serif; letter-spacing: normal; list-style-type: none; margin: 0px; padding-top: 1px; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px;">
<span style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;">Fonte:<span class="Apple-converted-space"> </span></span></span><a href="http://portalsaude.saude.gov.br/portalsaude/noticia/8945/785/svs-informa-aos-viajantes-cuidados-para-prevenir-a-gripe.html" style="color: #4f4d4d; font-family: Arial, Helvetica, sans-serif; list-style-type: none; margin: 0px; text-decoration: none;"><span style="font-family: arial, helvetica, sans-serif; list-style-type: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style-type: none; margin: 0px;"><span style="color: #0072bc; font-family: Arial, Helvetica, sans-serif; list-style-type: none; margin: 0px;">Ministério da Saúde</span></span></span></a></div>
Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-1851450626505237882013-01-16T05:55:00.001-08:002013-01-16T05:55:21.476-08:00Apreensão de Medicamentos<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;">Segundo o site da ANVISA, foi determinada a apreensão de medicamentos falsificados no Brasil. Os medicamentos são Hormotrop na apresentação de 12 unidades, Hytropin (Sulfato de Atropina), 0,50 mg/ml, fabricado pela empresa Hypofarma e o creme Fitomedic, feito da semente de Sucupira, fabricado pela empresa D.M. Cucio ME.</span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"><br /></span></div>
<div style="text-align: left;">
<span style="font-family: Arial, Helvetica, sans-serif;">A notícia completa está no link: </span></div>
<div style="text-align: left;">
<span style="color: #4f4d4d; font-family: arial, helvetica, sans-serif; font-size: x-small;"><br /></span></div>
<div style="text-align: left;">
<span style="color: #4f4d4d; font-family: arial, helvetica, sans-serif; font-size: x-small;">http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2013+noticias/agencia+determina+apreensao+de+medicamento+falsificado</span></div>
Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-1234792239175610222012-12-07T10:41:00.001-08:002012-12-07T10:41:59.883-08:00CALOUROS DA UFRGS FAZEM CAMPANHA PELO USO RACIONAL DE MEDICAMENTOSSob a orientação da Prof Irene Külkamp Guerreiro, os calouros da Faculdade de Farmácia da UFRGS foram para o centro histórico de Porto Alegre conversar com a população sobre o Uso Racional de Medicamentos. A campanha contou também com o apoio do Diretório Acadêmico da Faculdade de Farmácia (DAFF) e é promovida pela ENEFAR em todo o Brasil.<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
</div>
Diversos assuntos como o descarte correto de medicamentos, o uso adequado de antibióticos e outras orientações gerais sobre saúde foram repassadas à população promovendo o contato dos estudantes e o público.<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh-TIqBV9gq2LYVKN1dlwkTOpnLdpDeA2syDNtba4MwLpRWZLX-qmtPYbUbhKejqE3DBBT6tjs1tL2FB4la_VYy8BneEmVKOF7goMaXIoPzxjcCWA8491euAEwlqvPB9wARgyEttv_cfiE/s1600/bixos.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh-TIqBV9gq2LYVKN1dlwkTOpnLdpDeA2syDNtba4MwLpRWZLX-qmtPYbUbhKejqE3DBBT6tjs1tL2FB4la_VYy8BneEmVKOF7goMaXIoPzxjcCWA8491euAEwlqvPB9wARgyEttv_cfiE/s400/bixos.jpg" width="400" /></a></div>
Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-14877277734970492632012-11-27T15:05:00.003-08:002012-12-16T15:17:29.486-08:00Diagnóstico de comunidade como ferramenta para busca de causas de uso irracional de medicamentos - Rodrigo Silveira Pinto<b id="internal-source-marker_0.05226617678999901" style="font-weight: normal;"></b><br />
<div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<b id="internal-source-marker_0.05226617678999901" style="font-weight: normal;"><span style="font-size: 16px; vertical-align: baseline; white-space: pre-wrap;"></span></b></div>
<div class="separator" style="clear: both; text-align: center;">
<b id="internal-source-marker_0.05226617678999901" style="font-weight: normal;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjQIKwNXLkgejSzSz_ocIHaa7ozl-jqS2SzMViRDB2H6k0iCyQTn6kk58_MymHZ_zFXRtv7Wwo6pDup_vzE3XjJOmZu6SSPTlA8fgrC_cWjbP3Jn-ildJHuhXJKy17fXyRU9A1Wo4jS52Y/s1600/45242.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjQIKwNXLkgejSzSz_ocIHaa7ozl-jqS2SzMViRDB2H6k0iCyQTn6kk58_MymHZ_zFXRtv7Wwo6pDup_vzE3XjJOmZu6SSPTlA8fgrC_cWjbP3Jn-ildJHuhXJKy17fXyRU9A1Wo4jS52Y/s320/45242.jpg" width="238" /></a></b></div>
<div style="text-align: justify;">
<b id="internal-source-marker_0.05226617678999901" style="font-weight: normal;"><b id="internal-source-marker_0.05226617678999901" style="font-weight: normal;"></b></b><br />
<div dir="ltr" style="display: inline !important; margin-bottom: 0pt; margin-top: 0pt; text-indent: 35.45pt;">
<div style="text-align: justify;">
<b id="internal-source-marker_0.05226617678999901" style="font-weight: normal;"><b id="internal-source-marker_0.05226617678999901" style="font-weight: normal;"><span style="vertical-align: baseline;">A atuação profissional do farmacêutico vai muito além da produção e dispensação de medicamentos ou das análises clínicas. O perfil investigador em saúde também está presente na prática profissional como se vê no trabalho do mestrando Rodrigo Silveira Pinto. Nele o aluno faz um estudo retrospectivo sobre uma situação de saúde, buscando estabelecer as bases teóricas para realização de diagnóstico de comunidade utilizando dados da assistência farmacêutica.</span></b></b></div>
</div>
</div>
<div style="text-align: justify;">
<b id="internal-source-marker_0.05226617678999901" style="font-weight: normal;"><b style="font-weight: normal;">
</b></b></div>
<div style="text-align: justify;">
<br /></div>
<div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<div style="text-align: justify;">
<b id="internal-source-marker_0.05226617678999901" style="font-weight: normal;"><span style="font-size: 16px; vertical-align: baseline; white-space: pre-wrap;">Inicialmente será realizada revisão sistemática sobre métodos de diagnóstico de comunidade. Pretende-se com ela construir referencial teórico sobre intervenções realizadas pelo mestrando no município de Doutor Ulysses (PR), quando exerceu atividades de gestão da assistência farmacêutica, entre janeiro de 2010 a agosto de 2011. A partir da percepção do uso indiscriminado de anti-helmínticos, iniciou-se uma investigação do porquê desse uso irracional e o planejamento das intervenções necessárias. Analisando laudos da qualidade da água, diálogo com a comunidade, técnicos do serviço de saneamento e gestores municipais chegou-se à conclusão de que o problema estava na barreira de comunicação existente entre a comunidade e o serviço de saneamento, o qual ocasionava inadimplência, que gerava sucateamento do sistema causando perda da qualidade da água. A estratégia criada foi a reformulação da legislação do saneamento, inserindo a comunidade nas decisões do saneamento por meio da estruturação da Conferência Municipal de Saneamento e do Conselho Municipal de Saneamento, órgão este construído de forma paritária, com metade das cadeiras pertencentes a usuários e a outra metade formada por técnicos do serviço de saneamento, técnicos do serviço de saúde e gestores. Realizou-se então a 1ª Conferência Municipal de Saneamento, com a participação da comunidade, gestores, regional de saúde, profissionais de saúde e técnicos do serviço de saneamento local onde foram discutidos assuntos referentes a responsabilidades da comunidade e do serviço em oferecer um saneamento de qualidade.</span></b></div>
</div>
<div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<div style="text-align: justify;">
<b id="internal-source-marker_0.05226617678999901" style="font-weight: normal;"><span style="font-size: 16px; vertical-align: baseline; white-space: pre-wrap;"><br /></span></b></div>
</div>
<div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<div style="text-align: justify;">
<b id="internal-source-marker_0.05226617678999901" style="font-weight: normal;"><span style="font-size: 16px; vertical-align: baseline; white-space: pre-wrap;">A primeira análise deixa antever que o modelo biomédico de abordagem da saúde não atende a todas as situações, sendo necessário levar em consideração os determinantes sociais e ambientais da saúde na análise do consumo de medicamentos. A grande questão é como proceder para a realização dessas análises. Pode-se afirmar que de alguma forma o uso racional de medicamentos em nível individual não corresponde, necessariamente, a um uso racional de medicamentos em nível comunitário. </span></b></div>
</div>
<div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<div style="text-align: justify;">
<b id="internal-source-marker_0.05226617678999901" style="font-weight: normal;"><span style="font-size: 16px; vertical-align: baseline; white-space: pre-wrap;"><br /></span></b></div>
</div>
<div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<div style="text-align: justify;">
<b id="internal-source-marker_0.05226617678999901" style="font-weight: normal;"><span style="font-size: 16px; vertical-align: baseline; white-space: pre-wrap;">Para a realização desse projeto, Rodrigo que é orientando do Prof. Mauro de Castro, vai reunir documentações pertinentes a esses processos e recontar a história vivida.</span></b></div>
</div>
<div>
<b id="internal-source-marker_0.05226617678999901" style="font-weight: normal;"><span style="font-size: 16px; vertical-align: baseline; white-space: pre-wrap;"><br /></span></b></div>
Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com2tag:blogger.com,1999:blog-6704957047646129247.post-47366368367950370132012-11-02T17:31:00.000-07:002012-11-02T17:31:43.738-07:00Uso de Opióides em Crianças<span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;"><br /></span>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhjVp9jkWRKY6dndSuWzyHF5hr1QgBIFbNUh2im-M8Sw08rjFj4GXlaNT50hqHDTBSe-o3JzxU1XIWFx87Hi0upv5tP3p3kmOZf1QXu9klPloCKubBP6AxZjUGCvQ8P50zlAD-n0cNnKFQ/s1600/523140_10151099262379593_400171320_n.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhjVp9jkWRKY6dndSuWzyHF5hr1QgBIFbNUh2im-M8Sw08rjFj4GXlaNT50hqHDTBSe-o3JzxU1XIWFx87Hi0upv5tP3p3kmOZf1QXu9klPloCKubBP6AxZjUGCvQ8P50zlAD-n0cNnKFQ/s320/523140_10151099262379593_400171320_n.jpg" width="233" /></a></div>
<br />
<div style="text-align: justify;">
<span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;"> O aluno Gabriel Rodrigues Martins de Freitas está concluindo seu mestrado em Ciências Farmacêuticas na UFRGS, sob orientação da Prof.ª Dr.ª Isabella Heineck. O título de sua pesquisa é "Conhecimento e percepção (atitude) dos profissionais da saúde acerca do manejo da dor e uso de opióides na pediatria".</span></div>
<div style="text-align: justify;">
<span style="color: #222222; font-family: arial, sans-serif; font-size: 13px;"><br /></span></div>
<span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;"><div style="text-align: justify;">
A pesquisa surgiu do questionamento do Dr. Cláudio Galvão, na época oncologista do HCPA sobre o uso de medicamentos opióides ser mais aceito em crianças com câncer do que em crianças com outras patologias. Gabriel passou então a pesquisar sobre o tema e tentar descobrir o por quê do preconceito dessa indicação terapêutica dentro do próprio HCPA com profissionais ligados a pediatria dentro da UTI Pediátrica, da Oncologia Pediátrica e da Pediatria. Os profissionais de enfermagem, medicina e farmácia (122 ao total) responderam um longo questionário que avaliava a percepção e o conhecimento técnico deles a respeito de opióides utilizados por crianças. O trabalho com os questionários durou cerca de 3 meses e a maior dificuldade foi conseguir pessoas dispostas a responder suas questões.</div>
</span><div style="text-align: justify;">
<span style="color: #222222; font-family: arial, sans-serif; font-size: 13px;"><br /></span></div>
<span style="background-color: white; color: #222222; font-family: arial, sans-serif; font-size: 13px;"><div style="text-align: justify;">
Os resultados dessa pesquisa poderão ser conferidos na publicação do artigo que Gabriel está acabando de escrever. O trabalho deverá ser apresentado até março pelo aluno e passar pela banca de avaliação.</div>
<div style="text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEivtR0FcSUzIH2G3PB0Uxmme_9ZvErNCzbulLZMzXjl79jHR0pajSZjtKY3EYDFw6fFb5o3e0ovvTA_q0vdEyh-wcA1-TXPBChBrRXVsvL9sJZ1T-3c2nSGQjQkjBwjWnpIT_0OBowRbmc/s1600/jean-picton3-large.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="150" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEivtR0FcSUzIH2G3PB0Uxmme_9ZvErNCzbulLZMzXjl79jHR0pajSZjtKY3EYDFw6fFb5o3e0ovvTA_q0vdEyh-wcA1-TXPBChBrRXVsvL9sJZ1T-3c2nSGQjQkjBwjWnpIT_0OBowRbmc/s200/jean-picton3-large.jpg" width="200" /></a></div>
<div style="text-align: justify;">
<br /></div>
</span>Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-56591776863948312192012-10-13T17:17:00.003-07:002012-10-13T17:17:37.324-07:0084 CoNEEF<br />
<div class="MsoNormal" style="text-align: justify;">
Estou escrevendo diretamente da
cidade de Ceilândia - DF, onde estão ocorrendo parte das atividades do 84
CoNEEF. E, dessa vez, essa texto sai a
quatro mãos. Está colaborando a nossa colega e uma das coordenadoras do DAFF
Isis Petry. <o:p></o:p></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<b>O que é o CoNEEF?</b> O Conselho
Nacional de Entidades Estudantis de Farmácia é um encontro dos diretórios e
centros acadêmicos de todo o Brasil (das faculdades de Farmácia), realizado
trimestralmente obedecendo a um rodízio regional para que o maior número
possível de instituições possam participar das discussões.<o:p></o:p></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<b>O que acontece no CoNEEF?</b> Durante
o encontro é proporcionada a integração dos estudantes de Farmácia, a discussão
de assuntos relacionados às políticas de saúde no Brasil, às políticas ligadas
ao setor farmacêutico e às questões relacionadas ao ensino e pesquisa nas
faculdades brasileiras. Além disso, por fazer parte do Movimento Estudantil,
também são suscitadas questões de cunho social.<o:p></o:p></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<b>Por que é importante participar
do Movimento Estudantil?</b> Porque os movimentos estudantis costumam ter um papel
importante nas questões sociais, nas questões políticas e econômicas,
complementando a formação integral do cidadão. Uma vez inseridos nessas
discussões, o estudante desenvolve autonomia e senso crítico para tomar
posições conscientes e que podem melhorar as condições de vida da sua
comunidade.<o:p></o:p></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<b>Quem patrocina esses eventos?</b> A
comissão local do evento recolhe os valores de inscrição dos alunos
participantes e promove o evento em parceria com a ENEFAR (Executiva Nacional
dos Estudantes de Farmácia). Os próprios Centros e Diretórios Acadêmicos
patrocinam a ida de seus membros ao CoNEEF, mas existe a importante
participação de outras instituições para viabilizar a viagem dos alunos às
cidades onde o evento ocorre. É o caso da AFARGS, do Sindicato dos
Farmacêuticos do RS e do CRF-RS (que patrocinaram a ida dos membros do DAFF –
Diretório Acadêmico da Faculdade de Farmácia a Brasília). Ou seja, as
instituições representativas da classe farmacêutica acreditam na relevância
desse tipo de encontro e incentivam a participação dos futuros profissionais.<o:p></o:p></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
A seguir, foto de uma das plenárias do evento, na UnB - Campus Darcy Ribeiro:<o:p></o:p></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjBivxLwHSk6XYQM5HRvQc2jyP68mcSm2BB1svKz4kyTEly0b-x_Vt7rOV5LXmNNtq9VjdTSuXUNX9ijv1iLoIF7KU2YXg4JNdYE-WK4BB4RyBgba4oF4-hXTuK7Lhde0ZH2QKILEZFpD8/s1600/46864.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="400" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjBivxLwHSk6XYQM5HRvQc2jyP68mcSm2BB1svKz4kyTEly0b-x_Vt7rOV5LXmNNtq9VjdTSuXUNX9ijv1iLoIF7KU2YXg4JNdYE-WK4BB4RyBgba4oF4-hXTuK7Lhde0ZH2QKILEZFpD8/s400/46864.jpg" width="400" /></a></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-31640044143306985732012-09-30T14:05:00.002-07:002012-09-30T14:05:52.193-07:00Farmacêutico na Praça<div style="text-align: justify;">
<span style="background-color: white; color: #333333; line-height: 18px;"><span style="font-family: Arial, Helvetica, sans-serif;">Projeto "Farmacêutico na Praça" do CRF-RS, Afargs, Sindifars e Angarmag: primeira edição realizada no Parque Farroupilha nesse domingo, em comemoração a Semana Internacional do Farmacêutico. Foram realizados mil testes de glicemia, aferição de pressão arterial, orientação sobre o descarte consciente de medicamentos e consultas farmacêuticas.</span></span></div>
<div style="text-align: justify;">
<span style="background-color: white; color: #333333; line-height: 18px;"><span style="font-family: Arial, Helvetica, sans-serif;"><br /></span></span></div>
<div style="text-align: justify;">
<span style="background-color: white; color: #333333; line-height: 18px;"><span style="font-family: Arial, Helvetica, sans-serif;">Parabéns aos organizadores, ao alunos voluntários e aos Farmacêuticos voluntários!</span></span></div>
<div style="text-align: justify;">
<span style="background-color: white; color: #333333; line-height: 18px;"><span style="font-family: Arial, Helvetica, sans-serif;"><br /></span></span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"><span style="background-color: white; color: #333333; line-height: 18px;">Algumas fotos do evento (fonte Facebook </span><a href="https://www.facebook.com/media/set/?set=a.252813178161038.50691.100002970720266&type=1">Renova Inova</a> CRF-RS)</span></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"><br /></span></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi-kxttEGGPSbOKPSdFUwSDuTbQeQHTFUoQU3xSTEtXD8tOI9A-4-n8h3-UK2-Xk9ukLeVhy3iXUDR_ZWB84G8hyphenhyphenPxP1JyQyZKcCyZ4MBAlGS8g6lGfKxdzzaJjOea5TRW2K44RqxxECw0/s1600/229457_284985504943805_1724781796_n.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="640" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi-kxttEGGPSbOKPSdFUwSDuTbQeQHTFUoQU3xSTEtXD8tOI9A-4-n8h3-UK2-Xk9ukLeVhy3iXUDR_ZWB84G8hyphenhyphenPxP1JyQyZKcCyZ4MBAlGS8g6lGfKxdzzaJjOea5TRW2K44RqxxECw0/s640/229457_284985504943805_1724781796_n.jpg" width="480" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjV9yVqrExl5_Ksxi1CslkguO533azk5K9pItPU0QHjbr-kxS10QQYkkanEpakQA9KACB1CyehAjD1q0hkhSXjTQ6ltcTia1x_C6Ud-xfvsiKgURmQe9rFC8OlS4GgqX0D8Vo6zQJd_xM0/s1600/264270_284905078285181_761148710_n.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjV9yVqrExl5_Ksxi1CslkguO533azk5K9pItPU0QHjbr-kxS10QQYkkanEpakQA9KACB1CyehAjD1q0hkhSXjTQ6ltcTia1x_C6Ud-xfvsiKgURmQe9rFC8OlS4GgqX0D8Vo6zQJd_xM0/s400/264270_284905078285181_761148710_n.jpg" width="400" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhPv-UtfvlOuo7zGpx2vWfnIA_cn-8b6zUWU-fR_yuxtNFF28PzdkZx3o8lqtvhOQ_33lT1r5DFTRsuFp-NTtNUht2fGCfkkk4j-bYuoi5T2Zn7DU0rYSHmkXUQUW4TNj6dxY0nor5OJqk/s1600/299450_285002641608758_1056621756_n.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhPv-UtfvlOuo7zGpx2vWfnIA_cn-8b6zUWU-fR_yuxtNFF28PzdkZx3o8lqtvhOQ_33lT1r5DFTRsuFp-NTtNUht2fGCfkkk4j-bYuoi5T2Zn7DU0rYSHmkXUQUW4TNj6dxY0nor5OJqk/s400/299450_285002641608758_1056621756_n.jpg" width="400" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
</div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjfCtsDFu-y-GcdAMYyxk-WT6HlhdpQGFrj72rJmzm72LZ72CMKgbPCWgfmqwSI6jmDDStklN04jJQies5rI2RzmQjqWjoov1F7KQL4JiJLfOl4HGcqibnazDL73fvyuLA5OMIRV8njJVQ/s1600/422605_285005078275181_1965226031_n.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="240" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjfCtsDFu-y-GcdAMYyxk-WT6HlhdpQGFrj72rJmzm72LZ72CMKgbPCWgfmqwSI6jmDDStklN04jJQies5rI2RzmQjqWjoov1F7KQL4JiJLfOl4HGcqibnazDL73fvyuLA5OMIRV8njJVQ/s320/422605_285005078275181_1965226031_n.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhvzenERYUoP1uH4fu8cTB_YvGiIceINg4uyaveL0xV8I7g77K8rlSNA2WY5q1tW1Itq3vnwOnC814YSjDMzdN3rWRetq77gZxAU9rx39mM00N5TV23QnkrD55Nzf2vmwahejoRI02kQWk/s1600/480347_284915901617432_9465323_n.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="240" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhvzenERYUoP1uH4fu8cTB_YvGiIceINg4uyaveL0xV8I7g77K8rlSNA2WY5q1tW1Itq3vnwOnC814YSjDMzdN3rWRetq77gZxAU9rx39mM00N5TV23QnkrD55Nzf2vmwahejoRI02kQWk/s320/480347_284915901617432_9465323_n.jpg" width="320" /></a></div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhaoIK-EQlqd_ZE2yw5VSTq3HIWfweauM_JU2Hsvo8wAlDerK_aEhgHgTFh_kNbN_tZb8uuyTovkwrPQD_Yre-SlPqg3SViwIf8Siwva9VcqSiFQ8r-KW-pCk3vnmeWh-eNzrSepTnKLLs/s1600/603687_284997891609233_764432044_n.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="240" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhaoIK-EQlqd_ZE2yw5VSTq3HIWfweauM_JU2Hsvo8wAlDerK_aEhgHgTFh_kNbN_tZb8uuyTovkwrPQD_Yre-SlPqg3SViwIf8Siwva9VcqSiFQ8r-KW-pCk3vnmeWh-eNzrSepTnKLLs/s320/603687_284997891609233_764432044_n.jpg" width="320" /></a></div>
<div style="text-align: justify;">
<span style="font-family: Arial, Helvetica, sans-serif;"><br /></span></div>
Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-78120666502029040272012-09-29T15:45:00.000-07:002012-09-29T15:45:27.914-07:00Salão UFRGS 2012<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEigaH5WpCHX0d08ObMC0iXnqPVb_FbfHZQkH-aeTbxVcsWyVDVFDyjFp2HqocOWJXDLo4-TtO3M6pB_I7UgpU0Wf88xvssvQvQwvwI8ClooX7K2-qBofT3d5V8cHgSF02EkDTVT6mtmGcM/s1600/logo.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="82" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEigaH5WpCHX0d08ObMC0iXnqPVb_FbfHZQkH-aeTbxVcsWyVDVFDyjFp2HqocOWJXDLo4-TtO3M6pB_I7UgpU0Wf88xvssvQvQwvwI8ClooX7K2-qBofT3d5V8cHgSF02EkDTVT6mtmGcM/s400/logo.jpg" width="400" /></a></div>
<br />
<br />
As palavras do querido Prof. Rui sobre o Salão da UFRGS que se inicia na segunda-feira:<br />
<br />
"<span style="background-color: white; color: #222222; font-family: Arial, sans-serif; font-size: 10pt;">Prezados estudantes,</span><br />
<div class="MsoNormal" style="background-color: white; background-position: initial initial; background-repeat: initial initial; margin-bottom: 0.0001pt;">
<span style="color: #222222; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: PT-BR;">
<br />
De 1º a 5 de outubro estará ocorrendo o Salão UFRGS. Não deixe de participar
para além da eventual apresentação de seu trabalho. À disposição, uma
programação abrangente nas áreas de ensino, pesquisa e extensão. Aproveite para
conferir as novidades da Feira de Inovação FINOVA, tomar contato com o Campus
Internacional e suas variadas oportunidades, discutir questões ambientais,
acompanhar as atividades científicas de futuros cientistas no Salão Jovem e
assistir às atrações artísticas e culturais. Confira também os temas
“Universidade de Classe Mundial” e “Ciberconfluência: redes sociais, mobilidade
e educação” que serão abordados em dois painéis com a presença de convidados
especiais.<br />
<br />
Lembre-se: o Salão está na internet <a href="http://www.ufrgs.br/salaoufrgs2012" target="_blank"><span style="color: #1155cc;">www.ufrgs.br/salaoufrgs2012</span></a> , onde você
pode acompanhar tudo o que está programado tanto para o Campus Centro como para
o Campus do Vale.<br />
<br />
<span style="background: #FFFFCC;">Rui</span> Vicente Oppermann<br />
<a href="http://www.ufrgs.br/salaoufrgs2012">Salão UFRGS 2012</a><br />
Coordenador geral do Salão UFRGS"<o:p></o:p></span></div>
<div class="MsoNormal" style="background-color: white; background-position: initial initial; background-repeat: initial initial; margin-bottom: 0.0001pt;">
<span style="color: #222222; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: PT-BR;"><br /></span></div>
<div class="MsoNormal" style="background-color: white; background-position: initial initial; background-repeat: initial initial; margin-bottom: 0.0001pt;">
<span style="color: #222222; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: PT-BR;">Não dá prá perder, né? </span></div>
<div class="MsoNormal" style="background-color: white; background-position: initial initial; background-repeat: initial initial; margin-bottom: 0.0001pt;">
<span style="color: #222222; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: PT-BR;"><br /></span></div>
<div class="MsoNormal" style="background-color: white; background-position: initial initial; background-repeat: initial initial; margin-bottom: 0.0001pt;">
<span style="color: #222222; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: PT-BR;">Assiste aí o vídeo de divulgação:</span></div>
<div class="separator" style="clear: both; text-align: center;">
<iframe allowfullscreen='allowfullscreen' webkitallowfullscreen='webkitallowfullscreen' mozallowfullscreen='mozallowfullscreen' width='320' height='266' src='https://www.youtube.com/embed/5nMHMV73A3E?feature=player_embedded' frameborder='0'></iframe></div>
<div class="MsoNormal" style="background-color: white; background-position: initial initial; background-repeat: initial initial; margin-bottom: 0.0001pt;">
<span style="color: #222222; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: PT-BR;"><br /></span></div>
<div class="MsoNormal" style="background-color: white; background-position: initial initial; background-repeat: initial initial; margin-bottom: 0.0001pt;">
<span style="color: #222222; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: PT-BR;"><br /></span></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="MsoNormal" style="background-color: white; background-position: initial initial; background-repeat: initial initial; margin-bottom: 0.0001pt;">
<span style="color: #222222; font-family: "Arial","sans-serif"; font-size: 10.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: PT-BR;"><br /></span></div>
Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-37542361880822350512012-09-18T16:14:00.000-07:002012-09-18T16:21:33.735-07:00Desenvolvimento de Escores Para Determinação Da Complexidade Das Solicitações Recebidas Por Dois Centros De Informações Sobre Medicamentos (CIM) - TCC Raquel Guerra<b id="internal-source-marker_0.503730874042958" style="font-weight: normal;"></b><br />
<div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<b id="internal-source-marker_0.503730874042958" style="font-weight: normal;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiIQyZug63Mh15pGsslHxUbQkQs2vI_HN5hQVM67y9rLUe52GdbdSQVkS0pcMJDrRTAxN5F83GEzu_u6585vv08_AsQLZLBNAZkfVD5C24xbqYswGfp6thKbdU861Cxzhyphenhyphenwz3YRxoZFgFU/s1600/301839_319166684804543_326675218_n.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiIQyZug63Mh15pGsslHxUbQkQs2vI_HN5hQVM67y9rLUe52GdbdSQVkS0pcMJDrRTAxN5F83GEzu_u6585vv08_AsQLZLBNAZkfVD5C24xbqYswGfp6thKbdU861Cxzhyphenhyphenwz3YRxoZFgFU/s1600/301839_319166684804543_326675218_n.jpg" /></a><span style="font-size: 16px; vertical-align: baseline; white-space: pre-wrap;"></span></b></div>
<div style="text-align: justify;">
<div style="text-align: justify;">
<b id="internal-source-marker_0.503730874042958" style="font-weight: normal;"><b id="internal-source-marker_0.503730874042958" style="font-weight: normal; text-indent: 35.45pt;"><span style="vertical-align: baseline;"> A aluna Raquel Guerra da Silva estagiou no Centro de Informações sobre Medicamentos (CIM) do Hospital de Clínicas (HCPA) durante a sua graduação, percebendo que algumas solicitações recebidas pelo centro eram mais complexas do que outras. Isso faz com que a equipe demore mais na elaboração das respostas e precise consultar mais fontes. Para fazer um diagnóstico dessa situação aproveitou o momento do seu TCC e realizou o trabalho “Desenvolvimento de Escores Para Determinação Da Complexidade Das Solicitações Recebidas Por Dois Centros De Informações Sobre Medicamentos (CIM)”. Esse trabalho foi orientado pela Prof.ª Tatiane da Silva Dal Pizzol e co-orientado pela Farm. Luciana dos Santos. A entrada de questões do CIM RS gira em torno de 50 questões por mês. No HCPA, pela presença mais próxima dos profissionais, a média é de 120 questões por mês. Com esse escore é possível organizar melhor a função volume de trabalho VS organização. O projeto é relevante à medida que não há nenhum trabalho semelhante na literatura específica e pode contribuir para a qualificação dos serviços prestados pelos centros de informação. As poucas publicações na área de CIM são da década de 1970 e mais modernas costumam ter atualização a cada 4 anos, somente uma publicação registrou um estudo em que um tipo de escore conhecido determina fatores que afetam o tempo de desenvolvimento de uma resposta, esse da Noruega. Como o trabalho de Raquel era mais amplo, mais dados foram necessários para qualificar seu escore. Para busca de artigos de apoio, foi utilizado principalmente o Pubmed. </span></b></b></div>
</div>
<div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<div style="text-align: justify;">
<b style="font-weight: normal;"><span style="vertical-align: baseline; white-space: pre-wrap;"><br /></span></b></div>
</div>
<div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<div style="text-align: justify;">
<b id="internal-source-marker_0.503730874042958" style="font-weight: normal;"><span style="vertical-align: baseline; white-space: pre-wrap;">A integração do TCC entre os dois CIMs foi possível porque as duas farmacêuticas responsáveis pelos serviços eram as orientadoras do trabalho: a Prof.ª Tatiane do CIM – RS e a Farm. Luciana do CIM – HCPA, por isso a escolha da orientação para o trabalho foi natural e a participação delas foi efetiva.</span></b></div>
</div>
<div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<div style="text-align: justify;">
<b style="font-weight: normal;"><span style="vertical-align: baseline; white-space: pre-wrap;"><br /></span></b></div>
</div>
<div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<b id="internal-source-marker_0.503730874042958" style="font-weight: normal;"></b><br />
<div class="separator" style="clear: both; text-align: center;">
<b id="internal-source-marker_0.503730874042958" style="font-weight: normal;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj2ueuXQgk3AYOstgiXN7VaRR3A0d0m44wVPNKkVFBbkhF9Oq9yRKpZlq-Vh80nOvFZ-FmLyWtSFLKJOw43zBt8XbgiY9m2nn4OctUzx2eHP6dgsgiYSJub2JlapM9kqHZGI0DSIgY5QPk/s1600/PICT0034.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em; text-align: justify;"><img border="0" height="258" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj2ueuXQgk3AYOstgiXN7VaRR3A0d0m44wVPNKkVFBbkhF9Oq9yRKpZlq-Vh80nOvFZ-FmLyWtSFLKJOw43zBt8XbgiY9m2nn4OctUzx2eHP6dgsgiYSJub2JlapM9kqHZGI0DSIgY5QPk/s320/PICT0034.JPG" width="320" /></a></b></div>
<div style="text-align: justify;">
<b id="internal-source-marker_0.503730874042958" style="font-weight: normal;"><b id="internal-source-marker_0.503730874042958" style="font-weight: normal; text-indent: 35.45pt;"><span style="vertical-align: baseline; white-space: pre-wrap;">O escore ainda deve ser validado para que possa passar a fazer parte do dia-a-dia dos serviços, para isso a banca que avaliou o TCC sugeriu algumas alterações no trabalho. Tudo isso significa que, embora o TCC esteja pronto, o escore ainda tem que ser trabalhado pela aluna nas próximas etapas, sendo assim possível finalizar o processo e publicar o artigo. Para que esse ciclo seja encerrado com sucesso, Raquel irá realizar as próximas etapas, o que ainda deverá levar em torno de um ano. A aluna relata que a parte mais trabalhosa foi a digitação de mais de 300 questões (que foram escolhidas de modo aleatório nos dois serviços) e dos demais dados utilizados para a determinação do escore. Raquel também conta que ficou apreensiva em relação à banca, mas que as questões levantadas já constavam no próprio trabalho escrito e recebeu contribuições como o esperado.</span></b></b></div>
</div>
<div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<div style="text-align: justify;">
<b style="font-weight: normal;"><span style="vertical-align: baseline; white-space: pre-wrap;"><br /></span></b></div>
</div>
<div dir="ltr" style="margin-bottom: 0pt; margin-top: 0pt; text-align: justify; text-indent: 35.45pt;">
<div style="text-align: justify;">
<b id="internal-source-marker_0.503730874042958" style="font-weight: normal;"><span style="vertical-align: baseline; white-space: pre-wrap;">Depois da sua formatura, Raquel segue fazendo a ênfase em Análises Clínicas e começa sua vida de profissional farmacêutica em um hospital – como ela tanto desejava.</span></b></div>
</div>
<b id="internal-source-marker_0.503730874042958" style="font-weight: normal;"><span style="font-size: 16px; vertical-align: baseline; white-space: pre-wrap;"></span></b><br class="Apple-interchange-newline" />
<br />
<div>
<br /></div>
Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-88610113402060094612012-09-14T12:11:00.000-07:002012-09-14T12:11:19.688-07:00Katherine KrieserDESENVOLVIMENTO DE FORMULAÇÃO DE NANOCÁPSULAS DE SAQUINAVIR PARA TERAPIA
ANTIRETROVIRAL <br />
<br />
Katherine Krieser - orientada pela professora doutora
Irene Kulkamp Guerreiro.<br /><br />
Acadêmica da Facudade de Farmácia da Universidade Federal do Rio Grande do Sul e bolsista de iniciação tecnológica.<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<object width="320" height="266" class="BLOGGER-youtube-video" classid="clsid:D27CDB6E-AE6D-11cf-96B8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=6,0,40,0" data-thumbnail-src="http://0.gvt0.com/vi/LwFcABZoI_w/0.jpg"><param name="movie" value="http://www.youtube.com/v/LwFcABZoI_w&fs=1&source=uds" /><param name="bgcolor" value="#FFFFFF" /><param name="allowFullScreen" value="true" /><embed width="320" height="266" src="http://www.youtube.com/v/LwFcABZoI_w&fs=1&source=uds" type="application/x-shockwave-flash" allowfullscreen="true"></embed></object></div>
<br />Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-29408359236762140352012-09-07T05:27:00.001-07:002012-09-07T05:27:51.564-07:00TCC de Vinícius Altnetter - TCC “Avaliação da satisfação do usuário com o serviço prestado na Farmácia Popular do Brasil – UFRGS"<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgPLd0CjEylvhGF9Wc5uh9ewsGqGh4zTbttjP7-DeplzLzdZ__wSVOkDl3ImfggW9sjw88Yqtpb-AqVYbY0Tr2QUb7lwxivyhATkFjdFCMgg_3-F48bwtJ9KCudGf1iSfNBWZxq5mzIr00/s1600/285024_255708991121426_4147579_n.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgPLd0CjEylvhGF9Wc5uh9ewsGqGh4zTbttjP7-DeplzLzdZ__wSVOkDl3ImfggW9sjw88Yqtpb-AqVYbY0Tr2QUb7lwxivyhATkFjdFCMgg_3-F48bwtJ9KCudGf1iSfNBWZxq5mzIr00/s320/285024_255708991121426_4147579_n.jpg" width="232" /></a></div>
<br />
<div class="MsoNormal" style="text-align: justify; text-indent: 36.0pt;">
<span style="color: windowtext; font-family: Arial, sans-serif;">Nessa semana vamos conhecer um pouco
sobre o trabalho do aluno Vinícius Altnetter. Ele escreveu o TCC “Avaliação da
satisfação do usuário com o serviço prestado na Farmácia Popular do Brasil –
UFRGS”.<o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 36.0pt;">
<br /></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 36.0pt;">
<span style="color: windowtext; font-family: Arial, sans-serif;">Vinícius começa seu relato dizendo
que para a escolha de seu trabalho foi importante a sua participação nas
discussões que ocorreram sobre o tema no Diretório Acadêmico da Faculdade de
Farmácia (DAFF). Seu trabalho foi aplicar um questionário que procurava avaliar
a satisfação dos usuários com o serviço prestado pela farmácia escola. Para a
construção do questionário ele realizou a leitura de muitos artigos e conta que
a parte mais trabalhosa do TCC foi a elaboração dessas perguntas. Para a
aplicação do trabalho contou com o auxílio de toda a equipe da farmácia escola
(farmacêuticas, funcionárias e estagiários). Pelo auxílio, conselhos, apoio e
motivação dessa equipe, ele só tem a agradecer. <o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 36.0pt;">
<br /></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 36.0pt;">
<span style="color: windowtext; font-family: Arial, sans-serif;">A escolha da orientadora – assim como
a do trabalho em si – ocorreu de forma natural: pelo trabalho ativo da Prof.ª
Dr.ª Isabella Heineck na farmácia escola, ela foi a melhor opção. A Farm. Sara
Maria Gallina, a co-orientadora, também o incentivou muito com o trabalho. O
tempo de realização do TCC foi relativamente curto: da ideia ao trabalho final
escrito foram em torno de 100 dias. </span><span style="font-family: "Arial","sans-serif"; font-size: 8.0pt; mso-ansi-language: PT-BR; mso-bidi-font-size: 10.0pt;"><o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 36.0pt;">
<span style="color: windowtext; font-family: Arial, sans-serif;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 36.0pt;">
</div>
<div class="MsoNormal" style="text-indent: 36pt;">
<span style="font-family: Arial, sans-serif;">Nas palavras dele: “ler muitos artigos, pensar e
escrever” foram as tarefas desenvolvidas. Para a banca, a Prof.ª Isabella
indicou nomes de pessoas com conhecimento e experiência de sobra para avaliar o
trabalho.<o:p></o:p></span></div>
<div class="MsoNormal" style="text-indent: 36pt;">
<span style="font-family: Arial, sans-serif;"><br /></span></div>
<div class="MsoNormal" style="text-indent: 36pt;">
<span style="font-family: Arial, sans-serif;">O TCC já serviu à própria Farmácia Popular – UFRGS como uma resposta ao trabalho lá desenvolvido. Depois disso, Vinícius pretende submeter o trabalho às publicações da área para divulgar o belo trabalho da farmácia escola da UFRGS e para que todos os farmacêuticos que acreditam no futuro da profissão possam ser motivados.</span>
</div>
<div class="MsoNormal" style="text-indent: 36pt;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgkYJwQdhT22yHhYpt9YSkw_39DMnpK4sj3_956OK4SYsYuDN_3JooQLSdjQfLRQBa1mYJRhw-80wjZM27Qc07qTtdRbMmj5gavCpF1eaVPOqZkqGRKqBpo-4tP5KR9LyOR0_QEIuvbDKs/s1600/DSC08385.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="240" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgkYJwQdhT22yHhYpt9YSkw_39DMnpK4sj3_956OK4SYsYuDN_3JooQLSdjQfLRQBa1mYJRhw-80wjZM27Qc07qTtdRbMmj5gavCpF1eaVPOqZkqGRKqBpo-4tP5KR9LyOR0_QEIuvbDKs/s320/DSC08385.JPG" width="320" /></a></div>
<div class="MsoNormal" style="text-indent: 36pt;">
<br /></div>
<br />
Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-76623045256226262992012-08-24T18:18:00.000-07:002012-08-24T18:18:23.546-07:00Impacto da Obesidade na Farmacocinética - TCC de Jonas Mallmann<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh3dV2eWoggtMmwErxs2s79atvvpuwVv0OA-Wb669817qCYxQdHy8wAmlxH8e9LwzSnFSHqNNjKkdIs3OBySAmM98_7uS13mQACY_7TBWPpPnM_N3i9DQeEZkgd_tYHPuucxwK2rhjOR9o/s1600/423789_271288459616147_588154754_n.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="240" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh3dV2eWoggtMmwErxs2s79atvvpuwVv0OA-Wb669817qCYxQdHy8wAmlxH8e9LwzSnFSHqNNjKkdIs3OBySAmM98_7uS13mQACY_7TBWPpPnM_N3i9DQeEZkgd_tYHPuucxwK2rhjOR9o/s320/423789_271288459616147_588154754_n.jpg" width="320" /></a></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<!--[if gte vml 1]><v:shapetype
id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter"/>
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0"/>
<v:f eqn="sum @0 1 0"/>
<v:f eqn="sum 0 0 @1"/>
<v:f eqn="prod @2 1 2"/>
<v:f eqn="prod @3 21600 pixelWidth"/>
<v:f eqn="prod @3 21600 pixelHeight"/>
<v:f eqn="sum @0 0 1"/>
<v:f eqn="prod @6 1 2"/>
<v:f eqn="prod @7 21600 pixelWidth"/>
<v:f eqn="sum @8 21600 0"/>
<v:f eqn="prod @7 21600 pixelHeight"/>
<v:f eqn="sum @10 21600 0"/>
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
<o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="Imagem_x0020_1" o:spid="_x0000_s1027" type="#_x0000_t75"
style='position:absolute;left:0;text-align:left;margin-left:17.6pt;
margin-top:-.15pt;width:209.1pt;height:156.75pt;z-index:251658240;
visibility:visible;mso-wrap-style:square;mso-width-percent:0;
mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
mso-position-vertical:absolute;mso-position-vertical-relative:text;
mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;
mso-height-relative:page'>
<v:imagedata src="file:///C:\Users\CRISTI~1\AppData\Local\Temp\msohtmlclip1\01\clip_image001.jpg"
o:title=""/>
<w:wrap type="square"/>
</v:shape><![endif]--><!--[if !vml]--><!--[endif]--><span style="color: #222222; line-height: 150%;"><span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;">Na Série Trabalhos de Conclusão de
Curso (TCC) hoje apresentamos o trabalho do aluno <b><i>Jonas Mallmann</i></b> cujo
título é “Impacto da Obesidade na Farmacocinética”. O trabalho foi realizado
sob a orientação da Prof.ª Dr.ª Teresa Cristina Tavares Dalla Costa. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<br /></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;"><span style="color: #222222; line-height: 150%;">Os resultados desse trabalho foram
avaliados sob a utilização de β-bloqueadores, fármacos </span><span style="line-height: 150%;">antiarrítmicos, </span><span style="color: #222222; line-height: 150%;">antimicrobianos, antifúngicos, antivirais, anestésicos, outros fármacos
que atuam no sistema nervoso central, agentes quimioterápicos, agentes imunossupressores,
agentes anticoagulantes, contraceptivos orais, insulinas e outros fármacos em
geral.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<br /></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<span style="color: #222222; line-height: 150%;"><span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;">Na sequência temos a fala do próprio
Jonas sobre a experiência de realização do seu trabalho:<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<br /></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<span style="color: #222222; line-height: 150%;"><span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;">“Ao chegar no TCC, tinha na cabeça a
escolha por um tema que pudesse aplicar de maneira prática, algo que pudesse
ultrapassar os muros da universidade e ser levado adiante, algo que trouxesse
benefício à população de alguma maneira.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<br /></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<span style="color: #222222; line-height: 150%;"><span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;">Houve uma grande dificuldade na
escolha do tema, e nisso minha orientadora foi excelente ao resumir a ideia: ‘Qual
a pergunta que você quer responder que ninguém respondeu ainda, ou de que
maneira você quer responder que ninguém o tenha feito?’<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<br /></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;"><span style="color: #222222; line-height: 150%;">Quando cursei a disciplina de
farmacocinética (</span><span style="background-color: white; background-position: initial initial; background-repeat: initial initial; color: #222222; line-height: 150%;">que estuda os
processos de absorção, distribuição, biotransformação e excreção do fármaco no
organismo</span><span style="background-color: white; line-height: 150%;">)</span><span style="color: #222222; line-height: 150%;">, notei que diversas alterações
fisiológicas podem alterar o comportamento dos medicamentos no nosso organismo.
Juntei esta ideia com a minha experiência de atendimento em postos de saúde no
bairro Restinga, onde muitos dos diabéticos e hipertensos eram obesos.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<br /></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<span style="color: #222222; line-height: 150%;"><span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;">Levei, então, esta questão para a
professora Teresa Dalla Costa, na intenção de, através de revisão
bibliográfica, identificar o impacto das alterações fisiológicas causados pela
obesidade na farmacocinética de antidiabéticos e anti-hipertensivos. Não restringimos
data limite para a obtenção de artigos. Num primeiro momento, a pesquisa gerou
pouquíssimos resultados, parco demais para a elaboração de um TCC. Decidimos,
então, abrir totalmente, englobando qualquer tipo de fármaco, qualquer classe
terapêutica, desde que os resultados fossem expressos em humanos.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<br /></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<span style="color: #222222; line-height: 150%;"><span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;">Dos 614 resultados obtidos na
ferramenta <i>ISI Web of Science</i>, 97
artigos foram selecionados, dos quais 56 cumpriam os requisitos de serem
administrados em humanos, com grupo obeso versus controle não-obeso<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<br /></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<span style="color: #222222; line-height: 150%;"><span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;">A parte mais trabalhosa, obviamente,
foi ler na íntegra todos os 56 artigos (além ler o suficiente dos outros 41
para excluí-los), coletar as informações necessárias como método utilizado,
resultados, e a interpretação por parte dos autores, compilar a informação
obtida e tentar traçar algum comportamento em comum para medicamentos
semelhantes ou, ao menos, de comportamento semelhante (lipofílicos e
hidrofílicos, por exemplo).<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<br /></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<span style="color: #222222; line-height: 150%;"><span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;">Surpreendente foram os resultados, de
certa maneira, sendo impossível de traçar um comportamento padrão em
medicamentos semelhantes.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<br /></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<span style="color: #222222; line-height: 150%;"><span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;">Na elaboração do texto do trabalho, a
ajuda da minha orientadora foi fundamental para reorganizar todos aqueles dados
e conseguir apresentá-los de maneira coesa. E na análise dos resultados foi possível
entender o porquê dos resultados encontrados pelos autores. Diversos métodos
são empregados, com relativamente poucos indivíduos (média de 30 indivíduos),
não sendo possível traçar um comportamento naquele tipo de população.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<br /></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<span style="color: #222222; line-height: 150%;"><span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;">Para a escolha da banca, novamente
perguntei quais professores poderiam ler o trabalho feito e analisar de maneira
pertinente seu conteúdo. Minha orientadora então sugeriu chamar a prof.ª
Bibiana Verlindo de Araújo, pelo seu trabalho em farmacocinética, e a prof.ª
Isabela Heineck pelo trabalho que desenvolve com pacientes obesos.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; line-height: 150%; margin-bottom: .0001pt; margin-bottom: 0cm; text-align: justify; text-indent: 35.45pt;">
<br /></div>
<!--[if gte vml 1]><v:shape id="Imagem_x0020_2" o:spid="_x0000_s1026" type="#_x0000_t75"
style='position:absolute;margin-left:94pt;margin-top:486.7pt;width:316.8pt;
height:248.15pt;z-index:251659264;visibility:visible;mso-wrap-distance-left:9pt;
mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
mso-position-vertical-relative:margin' o:gfxdata="UEsDBBQABgAIAAAAIQCvatwyGAEAAIUCAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKRSvU7DMBDe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=
">
<v:imagedata src="file:///C:\Users\CRISTI~1\AppData\Local\Temp\msohtmlclip1\01\clip_image003.png"
o:title=""/>
<w:wrap type="square" anchorx="margin" anchory="margin"/>
</v:shape><![endif]--><!--[if !vml]--><!--[endif]--><span style="color: #222222; line-height: 115%;"><span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;">No futuro este trabalho pode ser o ponto de partida para outros
trabalhos com metodologia mais sólida ou então de um mestrado na área de
farmácia clínica, mas ainda é cedo pra dizer.”</span></span><br />
<span style="color: #222222; line-height: 115%;"><span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;"><br /></span></span>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgXXSDjJFEOufFHXsH6VboQBHj3vTKFRygJfBBVO7Y17cBSj2C4epkfionMN4JTZKWrcdwPnPDLkXB9-b0M_cekGWiciB8N9nDcT2nvQZe5GltsQLEqW9ntUWdGZgeajkYnKsqnysudiiQ/s1600/obeso.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgXXSDjJFEOufFHXsH6VboQBHj3vTKFRygJfBBVO7Y17cBSj2C4epkfionMN4JTZKWrcdwPnPDLkXB9-b0M_cekGWiciB8N9nDcT2nvQZe5GltsQLEqW9ntUWdGZgeajkYnKsqnysudiiQ/s400/obeso.jpg" width="400" /></a></div>
<span style="color: #222222; line-height: 115%;"><span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;"><br /></span></span>Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-11027790261714275172012-08-23T16:13:00.000-07:002012-08-23T16:13:26.999-07:00Recall de Preservativo<br />
<div style="font-family: Arial, Helvetica, sans-serif; font-size: 15px; line-height: 20px; padding: 0px; text-align: justify;">
A fabricante de preservativos Olla vai retirar do mercado 624 mil unidades do produto, que foram vendidas em embalagens promocionais tipo "leve 8 pague 6" dos lotes J12A0534,J12A0535, J12A0599, J12B0083, J12B0087.A empresa informa que a medida é um "recolhimento preventivo, pois identificou-se um desvio de qualidade que pode tornar o produto impróprio para o uso" . Procurada, a empresa não informou exatamente qual o problema encontrado nos preservativos e nem o período em que os lotes começaram a ser comercializados.</div>
<div style="font-family: Arial, Helvetica, sans-serif; font-size: 15px; line-height: 20px; padding: 0px; text-align: justify;">
A única informação é que a decisão de fazer o recall ocorreu em função do aumento do número de reclamação no Serviço de Atendimento ao Consumidor (SAC) da empresa.</div>
<div style="font-family: Arial, Helvetica, sans-serif; font-size: 15px; line-height: 20px; padding: 0px; text-align: justify;">
No total serão recolhidos 78 mil milhares do preservativo lubrificado promocional, com 8 unidades em cada um, número que representa 0,8% da produção anual da empresa. A identificação dos lotes pode ser encontrada no verso da embalagem. A orientação é que esses preservativos não sejam utilizados.</div>
<div style="font-family: Arial, Helvetica, sans-serif; font-size: 15px; line-height: 20px; padding: 0px; text-align: justify;">
"Caso algum produto destes lotes seja localizado, a Olla orienta os consumidores a não utilizá-lo, guardar sua embalagem e entrar em contato com o SAC pelo telefone 0800 0126888, ou pelo email atendimento@olla.com.br, para realizar a troca ou reembolso do produto, sem qualquer custo", informa a empresa em comunicado.</div>
<div style="font-family: Arial, Helvetica, sans-serif; font-size: 15px; line-height: 20px; padding: 0px;">
<br /></div>
<span style="font-family: Arial, Helvetica, sans-serif; font-size: 15px; line-height: 20px;"><div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiSEdwpOxJn43RZZ6UxaNe4nk3fQ-LgYHNtSsURu9AUvOghhDouzxWcBTeQqDbzwVAEuCt6Z_dDNe2NilWJZktkxcLEAII2qbejAY3xYNPw34cwUUudRQesQDseGW2BTDRy_90hLBCQH9Y/s1600/img-preservativo.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="240" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiSEdwpOxJn43RZZ6UxaNe4nk3fQ-LgYHNtSsURu9AUvOghhDouzxWcBTeQqDbzwVAEuCt6Z_dDNe2NilWJZktkxcLEAII2qbejAY3xYNPw34cwUUudRQesQDseGW2BTDRy_90hLBCQH9Y/s320/img-preservativo.jpg" width="320" /></a></div>
<span style="font-family: Arial, Helvetica, sans-serif; font-size: 15px; line-height: 20px;"><br /></span></span><span style="background-color: white; font-family: Arial, Helvetica, sans-serif; font-size: 15px; line-height: 20px;">Produtos foram vendidos em lotes promocionais “leve 8 pague 6”</span><span style="font-family: Arial, Helvetica, sans-serif; font-size: 15px; line-height: 20px;"><br /></span><span style="font-family: Arial, Helvetica, sans-serif; font-size: 15px; line-height: 20px;"></span><a href="http://oglobo.globo.com/economia/olla-faz-recall-de-mais-de-meio-milhao-de-preservativos-5879119">http://oglobo.globo.com/economia/olla-faz-recall-de-mais-de-meio-milhao-de-preservativos-5879119</a>
Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-30595004814668952232012-08-21T06:16:00.001-07:002012-08-21T06:16:05.622-07:00Humaniza SUS<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi4pxlCmgVItNNkPOyB6gevc-zhhAojMfbhDO2OPijoby46v3ddcy-_rK6nULvnYDVQqFzoPW7nVBTFLY1wkv4Ki4N0_T5d-oRl3i1ez7dmY_vggny8n9Duecw7xEDEbhW8Et_XQumHW_w/s1600/logo_pnh_versao_oficial.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="155" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi4pxlCmgVItNNkPOyB6gevc-zhhAojMfbhDO2OPijoby46v3ddcy-_rK6nULvnYDVQqFzoPW7nVBTFLY1wkv4Ki4N0_T5d-oRl3i1ez7dmY_vggny8n9Duecw7xEDEbhW8Et_XQumHW_w/s200/logo_pnh_versao_oficial.jpg" width="200" /></a></div>
<span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;"><span style="background-color: white; color: #636363;"><a href="http://www.blogger.com/goog_1459293104"><br /></a></span></span>
<div style="text-align: justify;">
<span style="color: #444444; font-family: Helvetica Neue, Arial, Helvetica, sans-serif;"><span style="background-color: white;"> </span><span style="background-color: white;"> A Política Nacional de Humanização existe desde 2003 para efetivar os princípios do SUS no cotidiano das </span><span style="background-color: white;">práticas</span><span style="background-color: white;"> de atenção e gestão, qualificando a saúde pública no Brasil e incentivando trocas solidárias entre gestores, trabalhadores e usuários.</span>
</span></div>
<div style="text-align: justify;">
<span style="color: #444444; font-family: Helvetica Neue, Arial, Helvetica, sans-serif;"><span style="background-color: white;"><a href="http://www.blogger.com/goog_1459293104"><br /></a></span></span></div>
<div style="text-align: justify;">
<span style="color: #444444; font-family: Helvetica Neue, Arial, Helvetica, sans-serif;"> No site do programa é possível encontrar esclarecimentos sobre o que é o Humaniza SUS, como participar, as redes humanizadas e publicações - em uma vasta biblioteca virtual.</span></div>
<div style="text-align: justify;">
<span style="color: #444444; font-family: Helvetica Neue, Arial, Helvetica, sans-serif;"><a href="http://www.blogger.com/goog_1459293104"><br /></a></span></div>
<span style="color: #444444; font-family: Helvetica Neue, Arial, Helvetica, sans-serif;"><div style="text-align: justify;">
Recentemente o Comitê Gaudério de Pesquisa realizou o II Encontro Estadual de Humanização PNH-RS foi lançada a pesquisa "FORMAÇÃO EM HUMANIZAÇÃO DO SUS: Avaliação dos efeitos dos processos de formação de apoiadores institucionais na produção de saúde nos territórios do Rio Grande do Sul, Santa Catarina e São Paulo".</div>
</span><span style="background-color: white; color: #444444; font-family: Arial, Helvetica, 'Lucida Grande', sans-serif; font-size: 14px; line-height: 23.78333282470703px;"><br /></span>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjEY9XzNeZ8HqqeyXA_jHOHt_-khdMkYk_xSmU5_bcMpCpa929kz_R86xhU7ZctRukB3_Zfnn97V3_S7Kf_Ov-f95y466M62PhWlesOdg5tc05dTRgp8cU2SHD5NEWUJxXXu6VJ_oawtHQ/s1600/comit%C3%AA+gaud%C3%A9rio+de+pesquisa.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="240" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjEY9XzNeZ8HqqeyXA_jHOHt_-khdMkYk_xSmU5_bcMpCpa929kz_R86xhU7ZctRukB3_Zfnn97V3_S7Kf_Ov-f95y466M62PhWlesOdg5tc05dTRgp8cU2SHD5NEWUJxXXu6VJ_oawtHQ/s320/comit%C3%AA+gaud%C3%A9rio+de+pesquisa.JPG" width="320" /></a></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhdGQNK-hzIjpdVq04BlGD_9tS9QcSIHJWeIEddhU-SPYmHZG6s2BvfCUxenwL7ZfiLpMcsUeIIcbgQy9S3ZrX4wyklrXJYHgar8sxZSmViNdbcb7GjfN2lgM035mfViEL75bS6a-Fn__A/s1600/moca_0.JPG" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="300" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhdGQNK-hzIjpdVq04BlGD_9tS9QcSIHJWeIEddhU-SPYmHZG6s2BvfCUxenwL7ZfiLpMcsUeIIcbgQy9S3ZrX4wyklrXJYHgar8sxZSmViNdbcb7GjfN2lgM035mfViEL75bS6a-Fn__A/s400/moca_0.JPG" width="400" /></a></div>
<div class="separator" style="clear: both; text-align: center;">
<br /></div>
<div style="text-align: center;">
<a href="http://www.redehumanizasus.net/13131-comit-gaud-rio-de-pesquisa-comemora-ii-encontro-pnh-rs">http://www.redehumanizasus.net/13131-comit-gaud-rio-de-pesquisa-comemora-ii-encontro-pnh-rs</a>
</div>
Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-60449148123644120382012-08-05T20:37:00.000-07:002012-08-05T20:37:12.483-07:00"Desenvolvimento de Modelo de Acompanhamento Farmacoterapêutico a Pacientes com Câncer de Mama Metastático em Tratamento de Capecitabina” - TCC de Guilherme Ehrenbrink<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg1MpDS5mknIwuDt-n5Y6Lt4WojEG2w77-vRB3j27UVItjIZHZKsTOIGFG0fQaWTiD_g977d8y1cuIAp4wojq7tmZYLq8B7OBYEL6VrLlt21BswuMAyp2ETF5-J2ZVId6PgveVqmcC7fD8/s1600/169238_3695672504777_489297658_o.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" height="150" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg1MpDS5mknIwuDt-n5Y6Lt4WojEG2w77-vRB3j27UVItjIZHZKsTOIGFG0fQaWTiD_g977d8y1cuIAp4wojq7tmZYLq8B7OBYEL6VrLlt21BswuMAyp2ETF5-J2ZVId6PgveVqmcC7fD8/s200/169238_3695672504777_489297658_o.jpg" width="200" /></a></div>
<br />
<div align="center" class="MsoNormal" style="text-align: center;">
<span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;"><b>Série: Trabalhos de
Conclusão de Curso (TCC) </b><o:p></o:p></span></div>
<div align="center" class="MsoNormal" style="text-align: center;">
<br /></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 35.45pt;">
<span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;">O formando
Guilherme Ehrenbrink apresentou seu TCC no último mês cujo título é
<b>“Desenvolvimento de Modelo de Acompanhamento Farmacoterapêutico a Pacientes com
Câncer de Mama Metastático em Tratamento de Capecitabina”</b>. Ele conta que, como
bolsista pesquisador no Grupo Hospitalar Conceição (GHC) trabalhou na equipe da
Farmacêutica Luciane P. Lindenmeyer (coordenadora do projeto de
farmacovigilância de medicamentos oncológicos do OTICS – parceira GHC e ANVISA)
acompanhando as pacientes em tratamento já há cerca de um ano quando chegou na
fase de realizar a disciplina do TCC. Percebendo que os dados que estava
coletando serviriam para realizar um projeto que tivesse aplicabilidade de
fato, resolveu aliar suas pesquisas à produção do TCC. Para isso contou com a
orientação da Profa. Dra. Farm. Isabela Heineck e a co-orientação do Farm.
Diego Wüst (também da equipe da Farm. Luciane Lindenmeyer).<span style="font-size: x-small;"><o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 35.45pt;">
<span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif; font-size: x-small;"><br /></span></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjriGOvnqOJyZ04Tj1g-ehMUeNiGk41zbQkE-4dO49CF-_9TyqjD6NoZ5LbLl93-6VW9iqaOJ0S6lsMLSCqIQkj_P54ZACSkiJQ1uueoIvrmIH99I1kHl3r8OPiopoFb3hywTBXM_etDmk/s1600/Xeloda_4d9b824103f90.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="160" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjriGOvnqOJyZ04Tj1g-ehMUeNiGk41zbQkE-4dO49CF-_9TyqjD6NoZ5LbLl93-6VW9iqaOJ0S6lsMLSCqIQkj_P54ZACSkiJQ1uueoIvrmIH99I1kHl3r8OPiopoFb3hywTBXM_etDmk/s200/Xeloda_4d9b824103f90.jpg" width="200" /></a></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 35.45pt;">
<span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif;">Guilherme
conta que a maior dificuldade que encontrou na elaboração do modelo foi
localizar ensaios clínicos randomizados e estudos de coortes que fossem
adequados ao seu estudo.<span style="line-height: 115%;"> </span><span class="a"><span style="background-color: white; background-position: initial initial; background-repeat: initial initial; border: 1pt none windowtext; padding: 0cm;">O ensaio clínico randomizado é um experimento que
tem por objetivo</span><span style="word-spacing: 2px;"> estudar os efeitos de uma
intervenção em particular. Os indivíduos selecionados são</span><span style="word-spacing: 4px;"> aleatoriamente alocados para os grupos intervenção e
controle, e os resultados são</span><span style="word-spacing: -3px;"> avaliados compara</span></span><span class="l6"><span style="background-color: white; background-position: initial initial; background-repeat: initial initial; border: 1pt none windowtext; padding: 0cm;">ndo-se os
desfechos entre</span></span><span class="apple-converted-space"><span style="background-color: white; background-position: initial initial; background-repeat: initial initial; border: 1pt none windowtext; padding: 0cm;"> <span style="display: inline-block;"></span></span><span class="l6"></span><span style="background-color: white; background-position: initial initial; background-repeat: initial initial; border: 1pt none windowtext; padding: 0cm;">esses grupos</span>.</span> <span style="background-color: white;">Os estudos de coorte são menos propensos aos vícios que podem
ocorrer nos estudos caso-controle e são os mais indicados para o estudo de
riscos, quando a experimentação não é possível</span><span style="background-color: white; line-height: 115%;">.</span> Pesquisando e lendo mais de uma centena de artigos,
encontrou apenas quatro que estavam dentro das delimitações necessárias para o
seu trabalho. Para realizar as buscas em bancos de dados de um modo mais
academicamente formal, notou que a sua experiência como aluno não era
suficiente e por isso contou com a consultoria da Biblioteconomista Maria
Eduarda dos Santos Puga (Centro Cochrane do Brasil). Com o material em mãos,
levou 1 mês para confeccionar o trabalho (entre escrever e revisar com os
orientadores). Elaborou o modelo planejando um fluxo de trabalho, listou exames
recomendados, confeccionou uma ficha para seguimento farmacoterapêutico e com
ela entrevistou cerca de 20 pacientes que estava acompanhando, detalhando os
efeitos da capecitabina e assim pôde detalhar os problemas relacionados a
medicamentos e as reações adversas medicamentosas. <span style="background-color: white;">Seguimento
Farmacoterapêutico é a<span class="apple-converted-space"> </span></span><span style="border: 1pt none windowtext; padding: 0cm;"> </span>prática em que o farmacêutico se responsabiliza
pelas necessidades do doente que estão relacionadas com os medicamentos,
através da detecção, prevenção e resolução dos Resultados Negativos da
Medicação (RNM), de<span class="apple-converted-space"> </span><span style="border: 1pt none windowtext; padding: 0cm;"> </span>modo contínuo, sistemático e documentado, em
colaboração com o próprio doente e com os outros profissionais da saúde, com o
objetivo de atingir resultados concretos que melhoram a qualidade de vida do
doente.<span style="font-size: x-small;"><o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 35.45pt;">
<span style="font-family: Helvetica Neue, Arial, Helvetica, sans-serif; font-size: x-small;"><br /></span></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgpHbyB5ECFVf1JgOc6o6e_PgQcUnrRULKppLqit1IpZIOFq5BBgunPWa3SjE5OmyGuYygjJrDMfMcYJzuv3A_mNC1wyNjtCNnR2qAYAGYS4DiU-l4ugbQwprWKTHukSqFqTWmCXNXCfbc/s1600/otics_ghc.png" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" height="65" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgpHbyB5ECFVf1JgOc6o6e_PgQcUnrRULKppLqit1IpZIOFq5BBgunPWa3SjE5OmyGuYygjJrDMfMcYJzuv3A_mNC1wyNjtCNnR2qAYAGYS4DiU-l4ugbQwprWKTHukSqFqTWmCXNXCfbc/s200/otics_ghc.png" width="200" /></a></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 35.45pt;">
<span style="font-family: 'Helvetica Neue', Arial, Helvetica, sans-serif; text-indent: 35.45pt;">O aluno ficou
bastante satisfeito com os resultados do trabalho considerando que ele é
bastante aplicável até mesmo para outros medicamentos oncológicos orais e que
não depende de onerar ainda mais o custo do tratamento dessas pacientes. Sobre
a apresentação à banca de TCC contou que foi bastante tranquila, pois já
possuía bastante conhecimento sobre o que apresentou. Como projeto futuro está
a ênfase em indústria que começa no segundo semestre letivo de 2012 e
aproveitar a sua formatura.</span></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 35.45pt;">
<span style="font-family: 'Helvetica Neue', Arial, Helvetica, sans-serif; font-size: x-small; text-indent: 35.45pt;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 35.45pt;">
<span style="font-family: 'Helvetica Neue', Arial, Helvetica, sans-serif; font-size: x-small; text-indent: 35.45pt;"><br /></span></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhv4MEjtHcHT-jM1kKSLdvm_zsomMel3lVzLIUBcuP_vAHZ4o_sg-L8Oi6oMWd8bESEPN99P6UI7Kw8YF1116qmD7mlR5db_6THPL4x7LpC6ZEIfSW7wmlsW4uY-z8RQ_RCEjIbUqPltEk/s1600/img.ptg.2.1.02.6020.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="240" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhv4MEjtHcHT-jM1kKSLdvm_zsomMel3lVzLIUBcuP_vAHZ4o_sg-L8Oi6oMWd8bESEPN99P6UI7Kw8YF1116qmD7mlR5db_6THPL4x7LpC6ZEIfSW7wmlsW4uY-z8RQ_RCEjIbUqPltEk/s320/img.ptg.2.1.02.6020.jpg" width="320" /></a></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 35.45pt;">
<span style="font-family: 'Helvetica Neue', Arial, Helvetica, sans-serif; font-size: x-small; text-indent: 35.45pt;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify; text-indent: 35.45pt;">
<o:p></o:p></div>Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-53269595634396876882012-08-05T20:15:00.000-07:002012-08-05T20:15:40.313-07:00<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjcrIBtX15iJcpr2AWYze3Sig_A423TdQemPUlFORGcFWtBlqbFO3JLwhLN0q-z2DeovFSmw0nAAFAfLgk5wyyxI0QXOfGd19LqBCWikOqOEKWztCFp3Aj4wfPcrZmutIzJk5_OvTOXxVE/s1600/farm%25C3%25A1cia.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="200" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjcrIBtX15iJcpr2AWYze3Sig_A423TdQemPUlFORGcFWtBlqbFO3JLwhLN0q-z2DeovFSmw0nAAFAfLgk5wyyxI0QXOfGd19LqBCWikOqOEKWztCFp3Aj4wfPcrZmutIzJk5_OvTOXxVE/s200/farm%25C3%25A1cia.jpg" width="200" /></a></div>
<div style="text-align: justify;">
<span style="background-color: white; color: #333333; font-family: 'lucida grande', tahoma, verdana, arial, sans-serif; line-height: 17px;"><br /></span></div>
<div style="text-align: justify;">
<span style="background-color: white; color: #333333; font-family: 'lucida grande', tahoma, verdana, arial, sans-serif; line-height: 17px;">Muitas ideias interessantes e inovadoras surgem dos TCCs dos alunos da FacFar. Por isso, vamos iniciar uma série de entrevistas com os alunos falando sobre o seu trabalho (desde a formulação até a banca), as dificuldades e as conquistas alcançadas com ele. Se você já fez seu TCC e também quiser divulgar, procure o blog e vamos compartilhar conhecimento! :)</span></div>Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-10518060926925948382012-07-24T12:18:00.001-07:002012-07-24T12:34:41.638-07:00Assistência Farmacêutica - Portal da Saúde<div style="text-align: left;">
<span style="background-color: white; font-family: 'Helvetica Neue', Arial, Helvetica, sans-serif; text-align: justify;"> O Portal da Saúde do Ministério da Saúde possui um espaço totalmente voltado para a Assistência Farmacêutica. Neste espaço é possível acessar detalhes sobre o tema além de manuais específicos para farmacêuticos, destaques, premiações, fóruns, legislação específica, diretrizes e muito mais. Para acessar o conteúdo basta clicar no link: </span></div>
<br />
<a href="http://portal.saude.gov.br/portal/saude/profissional/area.cfm?id_area=1000" style="background-color: white; font-family: 'Helvetica Neue', Arial, Helvetica, sans-serif; text-align: justify;">http://portal.saude.gov.br/portal/saude/profissional/area.cfm?id_area=1000</a><span style="background-color: white; font-family: 'Helvetica Neue', Arial, Helvetica, sans-serif; text-align: justify;"> </span><br />
<div style="text-align: justify;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj-ujsBYIdgItxH0CKYW6xKP8Ji3gXD0KgPDDVAWucgkjjAW6Ik2MACHMSvfoETfzjhAUdkI_tz8GRWAJNvQGnnwRdbTpfzltKHvadaxGorh2fV1a-3GKEAsFEBaI9sUXOETlWsG-YCv88/s1600/assist%C3%AAncia+farmac%C3%AAutica.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="60" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj-ujsBYIdgItxH0CKYW6xKP8Ji3gXD0KgPDDVAWucgkjjAW6Ik2MACHMSvfoETfzjhAUdkI_tz8GRWAJNvQGnnwRdbTpfzltKHvadaxGorh2fV1a-3GKEAsFEBaI9sUXOETlWsG-YCv88/s200/assist%C3%AAncia+farmac%C3%AAutica.jpg" width="200" /></a></div>
<br />
<br />Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-31501646782807133422012-07-21T08:41:00.000-07:002012-07-21T08:41:23.096-07:00Farmacovigilância - ANVISA<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhEdHTff7iuwJ2ct0wZz4vBQ0K3yykWDyyliSIGS3JYld7Mh_Aq9CNFM4uartABU01rG6LjMqjprFpiUF2qLDxAyCffWLTuiy3f-Z9C4f8GLfkfpvvBvuP-RAogaT4ceIPLuZYMQPcm_x8/s1600/farmacovigil%C3%A2ncia.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" height="200" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhEdHTff7iuwJ2ct0wZz4vBQ0K3yykWDyyliSIGS3JYld7Mh_Aq9CNFM4uartABU01rG6LjMqjprFpiUF2qLDxAyCffWLTuiy3f-Z9C4f8GLfkfpvvBvuP-RAogaT4ceIPLuZYMQPcm_x8/s200/farmacovigil%C3%A2ncia.jpg" width="200" /></a></div>
<span style="background-color: white; font-family: 'Helvetica Neue', Arial, Helvetica, sans-serif; list-style: none; margin: 0px; text-align: justify;"><span style="list-style: none; margin: 0px;">A Anvisa lançou, no dia 10/7/12, a primeira edição do </span></span><span style="background-color: white; font-family: 'Helvetica Neue', Arial, Helvetica, sans-serif; list-style: none; margin: 0px; text-align: justify;"><span style="list-style: none; margin: 0px;"><span style="list-style: none; margin: 0px;"><b>Boletim de Farmacovigilância</b></span></span></span><span style="background-color: white; font-family: 'Helvetica Neue', Arial, Helvetica, sans-serif; list-style: none; margin: 0px; text-align: justify;"><span style="list-style: none; margin: 0px;">. O documento apresenta um histórico da Farmacovigilância no Brasil, com exemplos de medicamentos retirados do mercado por problemas relacionados a eventos adversos ao longo dos anos, além da definição de conceitos básicos.</span></span><br />
<span style="font-family: 'Helvetica Neue', Arial, Helvetica, sans-serif;"><span style="list-style: none; margin: 0px;"></span></span><br />
<div style="text-align: justify;">
<span style="font-family: 'Helvetica Neue', Arial, Helvetica, sans-serif;"><br /></span></div>
<span style="font-family: 'Helvetica Neue', Arial, Helvetica, sans-serif;"><span style="list-style: none; margin: 0px;"><div style="text-align: justify;">
<span style="background-color: white;">Com periodicidade trimestral, o boletim divulga, também, o cenário das notificações de eventos adversos recebidos por meio do Sistema de Notificações em Vigilância Sanitária (Notivisa), no período de 2008 a 2011, e as últimas comunicações sobre segurança de medicamentos.</span></div>
<div style="text-align: justify;">
<span style="background-color: white;"><br /></span></div>
<div style="text-align: justify;">
<span style="background-color: white;">Para acessar, basta clicar no link abaixo:</span></div>
</span></span><br />
<span style="color: #4f4d4d; font-family: arial, helvetica, sans-serif; list-style: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; list-style: none; margin: 0px;"><a href="http://portal.anvisa.gov.br/wps/wcm/connect/fac881804bed0acd9451ddbc0f9d5b29/Farmaco+1.pdf?MOD=AJPERES">http://portal.anvisa.gov.br/wps/wcm/connect/fac881804bed0acd9451ddbc0f9d5b29/Farmaco+1.pdf?MOD=AJPERES</a>
</span></span><br />
<span style="color: #4f4d4d; font-family: arial, helvetica, sans-serif; font-size: 12px; list-style: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style: none; margin: 0px;"><br /></span></span><br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiUrH7G6oF6lbfjWNiFg8WY7SUTdI_MHIq3kV951ksfbk249nA6D9U4hRZTTs2-BEsYMbJtlaBw83sULpWwUhAT5ovDorveGCOAoSip4jDCy862L_7v7itaGBl0-TtSye6B5PfzsaN79Ck/s1600/anvisa.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="88" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiUrH7G6oF6lbfjWNiFg8WY7SUTdI_MHIq3kV951ksfbk249nA6D9U4hRZTTs2-BEsYMbJtlaBw83sULpWwUhAT5ovDorveGCOAoSip4jDCy862L_7v7itaGBl0-TtSye6B5PfzsaN79Ck/s200/anvisa.jpg" width="200" /></a></div>
<span style="color: #4f4d4d; font-family: arial, helvetica, sans-serif; font-size: 12px; list-style: none; margin: 0px;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; list-style: none; margin: 0px;"><br /></span></span>Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0tag:blogger.com,1999:blog-6704957047646129247.post-2444629647208721922012-07-20T18:43:00.000-07:002012-07-20T18:43:26.633-07:00Feliz Dia do Amigo!<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjl_U6JPwYna1Ikmo6U7A2-HefVPHt3-eAvAUhpL4CtENfhJ-w6-bkU7F7efCDafj6py5YKkRNLac8QtfvLf-kAiwXXAMoyg2_nZndWiNKiE4uh2hZsBtN38OyT1M-1TJRHNtiaEiwmK7A/s1600/planeta.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjl_U6JPwYna1Ikmo6U7A2-HefVPHt3-eAvAUhpL4CtENfhJ-w6-bkU7F7efCDafj6py5YKkRNLac8QtfvLf-kAiwXXAMoyg2_nZndWiNKiE4uh2hZsBtN38OyT1M-1TJRHNtiaEiwmK7A/s1600/planeta.jpg" /></a></div>
<br />Pesquisas Científicas -Farmácia UFRGShttp://www.blogger.com/profile/09018741486674874951noreply@blogger.com0